CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: sotorasib
Accession: CHEBI:178199
browse the term
Definition: A pyridopyrimidine that is pyrido[2,3-d]pyrimidin-2(1H)-one substituted by 4-methyl-2-(propan-2-yl)pyridin-3-yl, (2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl, fluoro and 2-fluoro-6-hydroxyphenyl groups at positions 1, 4, 6 and 7, respectively. It is approved for the treatment of patients with non-small cell lung cancer having KRAS(G12C) mutations.
Synonyms: exact_synonym: 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-4-[(2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl]pyrido[2,3-d]pyrimidin-2(1H)-one
related_synonym: AMG-510; AMG510; Formula=C30H30F2N6O3; InChI=1S/C30H30F2N6O3/c1-6-23(40)36-12-13-37(18(5)15-36)28-19-14-21(32)26(24-20(31)8-7-9-22(24)39)34-29(19)38(30(41)35-28)27-17(4)10-11-33-25(27)16(2)3/h6-11,14,16,18,39H,1,12-13,15H2,2-5H3/t18-/m0/s1; InChIKey=NXQKSXLFSAEQCZ-SFHVURJKSA-N; Lumakras; SMILES=CC(C)C1=NC=CC(C)=C1N1C(=O)N=C(N2CCN(C[C@@H]2C)C(=O)C=C)C2=C1N=C(C(F)=C2)C1=C(F)C=CC=C1O; sotorasibum
xref: CAS:2296729-00-3; Chemspider:72380148; DrugBank:DB15569; KEGG:D12055
xref_mesh: MESH:C000706028
xref: PMID:31189530; PMID:31666701; PMID:31820981; PMID:32540954; PMID:32686745; PMID:32955176; PMID:33283304; PMID:33466360; PMID:33547148; PMID:33957355; PMID:33971321; PMID:34004237; PMID:34043291; PMID:34094546; PMID:34096690; PMID:34137282; PMID:34140669; PMID:34144959; PMID:34158284; PMID:34219153; PMID:34301758; PMID:34357500; PMID:34359807; Wikipedia:Sotorasib
G
4921524L21Rikl1
RIKEN cDNA 4921524L21 gene like 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CCDC144BP mRNA
CTD
PMID:36139627
NCBI chr17:54,808,184...54,847,675
Ensembl chr17:54,808,184...54,847,671 Ensembl chr17:54,808,184...54,847,671
G
Aadat
aminoadipate aminotransferase
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of AADAT mRNA
CTD
PMID:36139627
NCBI chr16:29,509,392...29,544,332
Ensembl chr16:29,509,394...29,544,332
G
Abhd11
abhydrolase domain containing 11
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ABHD11 mRNA
CTD
PMID:36139627
NCBI chr12:21,682,206...21,685,331
Ensembl chr12:21,682,202...21,685,398
G
Ache
acetylcholinesterase
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ACHE mRNA
CTD
PMID:36139627
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Acp7
acid phosphatase 7, tartrate resistant
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ACP7 mRNA
CTD
PMID:36139627
NCBI chr 1:83,896,485...83,923,436
Ensembl chr 1:83,898,153...83,920,634
G
Acsl5
acyl-CoA synthetase long-chain family member 5
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ACSL5 mRNA
CTD
PMID:36139627
NCBI chr 1:254,289,513...254,336,608
Ensembl chr 1:254,292,521...254,336,607
G
Acsm3
acyl-CoA synthetase medium-chain family member 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ACSM3 mRNA
CTD
PMID:36139627
NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184
G
Acta2
actin alpha 2, smooth muscle
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ACTA2 mRNA
CTD
PMID:36139627
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Actbl2
actin, beta-like 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ACTBL2 mRNA
CTD
PMID:36139627
NCBI chr 2:42,858,020...42,860,767
Ensembl chr 2:42,858,020...42,860,767
G
Acy3
aminoacylase 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ACY3 mRNA
CTD
PMID:36139627
NCBI chr 1:201,279,751...201,285,803
Ensembl chr 1:201,279,851...201,283,175
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ADAMTS1 mRNA
CTD
PMID:36139627
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
G
Adamts16
ADAM metallopeptidase with thrombospondin type 1 motif, 16
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ADAMTS16 mRNA
CTD
PMID:36139627
NCBI chr 1:32,430,436...32,562,481
Ensembl chr 1:32,430,436...32,560,494
G
Adamts4
ADAM metallopeptidase with thrombospondin type 1 motif, 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ADAMTS4 mRNA
CTD
PMID:36139627
NCBI chr13:83,670,556...83,680,045
Ensembl chr13:83,670,183...83,680,065
G
Adamts6
ADAM metallopeptidase with thrombospondin type 1 motif, 6
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ADAMTS6 mRNA
CTD
PMID:36139627
NCBI chr 2:35,421,483...35,633,305
Ensembl chr 2:35,421,510...35,633,298
G
Adgrg1
adhesion G protein-coupled receptor G1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ADGRG1 mRNA
CTD
PMID:36139627
NCBI chr19:10,003,963...10,041,122
Ensembl chr19:10,003,975...10,041,108
G
Adgrl3
adhesion G protein-coupled receptor L3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ADGRL3 mRNA
CTD
PMID:36139627
NCBI chr14:26,336,320...27,104,060
Ensembl chr14:26,368,277...27,105,860
G
Adrb2
adrenoceptor beta 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ADRB2 mRNA
CTD
PMID:36139627
NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
G
Afap1l1
actin filament associated protein 1-like 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of AFAP1L1 mRNA
CTD
PMID:36139627
NCBI chr18:55,183,786...55,244,174
Ensembl chr18:55,183,786...55,244,146
G
Agr2
anterior gradient 2, protein disulphide isomerase family member
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of AGR2 mRNA
CTD
PMID:36139627
NCBI chr 6:52,708,602...52,729,378
Ensembl chr 6:52,708,602...52,729,371
G
Akap5
A-kinase anchoring protein 5
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of AKAP5 mRNA
CTD
PMID:36139627
NCBI chr 6:95,051,527...95,061,075
Ensembl chr 6:95,051,537...95,061,578
G
Akna
AT-hook transcription factor
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of AKNA mRNA
CTD
PMID:36139627
NCBI chr 5:76,777,415...76,824,380
Ensembl chr 5:76,777,415...76,816,017
G
Akt3
AKT serine/threonine kinase 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of AKT3 mRNA
CTD
PMID:36139627
NCBI chr13:88,943,708...89,225,831
Ensembl chr13:88,946,091...89,225,708
G
Aldh1a2
aldehyde dehydrogenase 1 family, member A2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ALDH1A2 mRNA
CTD
PMID:36139627
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
G
Aldoc
aldolase, fructose-bisphosphate C
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ALDOC mRNA
CTD
PMID:36139627
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
G
Aloxe3
arachidonate epidermal lipoxygenase 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ALOXE3 mRNA
CTD
PMID:36139627
NCBI chr10:53,830,219...53,854,328
Ensembl chr10:53,831,264...53,854,328
G
Alpg
alkaline phosphatase, germ cell
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ALPG mRNA
CTD
PMID:36139627
NCBI chr 9:87,748,721...87,761,500
Ensembl chr 9:87,753,648...87,757,836
G
Amn1
antagonist of mitotic exit network 1 homolog
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of AMN1 mRNA
CTD
PMID:36139627
NCBI chr 4:182,155,140...182,182,085
Ensembl chr 4:182,155,142...182,182,016
G
Ampd3
adenosine monophosphate deaminase 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of AMPD3 mRNA
CTD
PMID:36139627
NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887
G
Ang
angiogenin
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ANG mRNA
CTD
PMID:36139627
NCBI chr15:24,312,711...24,323,361
G
Angptl4
angiopoietin-like 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ANGPTL4 mRNA
CTD
PMID:36139627
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
G
Ank3
ankyrin 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ANK3 mRNA
CTD
PMID:36139627
NCBI chr20:18,602,267...19,225,831
Ensembl chr20:18,602,786...19,086,300
G
Ankef1
ankyrin repeat and EF-hand domain containing 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ANKEF1 mRNA
CTD
PMID:36139627
NCBI chr 3:123,847,832...123,883,060
Ensembl chr 3:123,847,817...123,883,059
G
Ankrd2
ankyrin repeat domain 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ANKRD2 mRNA
CTD
PMID:36139627
NCBI chr 1:240,847,111...240,856,563
Ensembl chr 1:240,847,072...240,856,566
G
Ankrd24
ankyrin repeat domain 24
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ANKRD24 mRNA
CTD
PMID:36139627
NCBI chr 7:8,061,634...8,081,142
Ensembl chr 7:8,061,953...8,081,142
G
Ankrd37
ankyrin repeat domain 37
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ANKRD37 mRNA
CTD
PMID:36139627
NCBI chr16:46,268,933...46,271,971
Ensembl chr16:46,268,443...46,271,963
G
Ankrd65
ankyrin repeat domain 65
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ANKRD65 mRNA
CTD
PMID:36139627
NCBI chr 5:166,398,359...166,400,616
Ensembl chr 5:166,397,748...166,400,953
G
Ano7
anoctamin 7
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ANO7 mRNA
CTD
PMID:36139627
NCBI chr 9:93,917,524...93,945,323
Ensembl chr 9:93,917,524...93,945,323
G
Anpep
alanyl aminopeptidase, membrane
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ANPEP mRNA
CTD
PMID:36139627
NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:133,767,332...133,785,789
G
Aoc3
amine oxidase, copper containing 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of AOC3 mRNA
CTD
PMID:36139627
NCBI chr10:86,272,757...86,280,702
G
Apln
apelin
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of APLN mRNA
CTD
PMID:36139627
NCBI chr X:127,180,801...127,213,567
Ensembl chr X:127,203,823...127,213,391
G
Apobr
apolipoprotein B receptor
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of APOBR mRNA
CTD
PMID:36139627
NCBI chr 1:181,169,019...181,173,206
Ensembl chr 1:181,168,916...181,173,528
G
Arfgef3
ARFGEF family member 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ARFGEF3 mRNA
CTD
PMID:36139627
NCBI chr 1:13,245,578...13,404,319
Ensembl chr 1:13,244,830...13,404,084
G
Arhgap31
Rho GTPase activating protein 31
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ARHGAP31 mRNA
CTD
PMID:36139627
NCBI chr11:62,038,635...62,151,564
Ensembl chr11:62,038,635...62,151,564
G
Arhgap8
Rho GTPase activating protein 8
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ARHGAP8 mRNA
CTD
PMID:36139627
NCBI chr 7:115,842,223...115,902,094
Ensembl chr 7:115,850,654...115,902,093
G
Armh1
armadillo-like helical domain containing 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ARMH1 mRNA
CTD
PMID:36139627
NCBI chr 5:130,680,955...130,722,062
Ensembl chr 5:130,682,485...130,722,062
G
Atg9b
autophagy related 9B
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ATG9B mRNA
CTD
PMID:36139627
NCBI chr 4:10,784,934...10,793,832
Ensembl chr 4:10,786,114...10,793,651
G
Atp10d
ATPase phospholipid transporting 10D (putative)
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ATP10D mRNA
CTD
PMID:36139627
NCBI chr14:35,911,728...36,012,549
Ensembl chr14:35,912,141...36,012,564
G
Atp13a3
ATPase 13A3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ATP13A3 mRNA
CTD
PMID:36139627
NCBI chr11:70,364,998...70,442,005
Ensembl chr11:70,365,322...70,441,235
G
Atp2a3
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ATP2A3 mRNA
CTD
PMID:36139627
NCBI chr10:57,581,742...57,612,758
Ensembl chr10:57,582,128...57,612,748
G
Atp6v0d2
ATPase H+ transporting V0 subunit D2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ATP6V0D2 mRNA
CTD
PMID:36139627
NCBI chr 5:33,336,257...33,385,354
Ensembl chr 5:33,336,264...33,385,354
G
Avil
advillin
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of AVIL mRNA
CTD
PMID:36139627
NCBI chr 7:62,825,459...62,844,103
Ensembl chr 7:62,826,025...62,844,071
G
Bach2
BTB domain and CNC homolog 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of BACH2 mRNA
CTD
PMID:36139627
NCBI chr 5:46,632,338...46,982,676
Ensembl chr 5:46,638,317...46,977,877
G
Bambi
BMP and activin membrane-bound inhibitor
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of BAMBI mRNA
CTD
PMID:36139627
NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060
G
Barx2
BARX homeobox 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of BARX2 mRNA
CTD
PMID:36139627
NCBI chr 8:30,251,132...30,319,105
Ensembl chr 8:30,251,132...30,319,013
G
Batf3
basic leucine zipper ATF-like transcription factor 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of BATF3 mRNA
CTD
PMID:36139627
NCBI chr13:102,689,657...102,701,241
Ensembl chr13:102,689,657...102,701,139
G
Bcl2l14
Bcl2-like 14
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of BCL2L14 mRNA
CTD
PMID:36139627
NCBI chr 4:167,217,561...167,258,723
Ensembl chr 4:167,219,871...167,258,086
G
Bco2
beta-carotene oxygenase 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of BCO2 mRNA
CTD
PMID:36139627
NCBI chr 8:50,882,174...50,907,676
Ensembl chr 8:50,882,181...50,915,467
G
Bex1
brain expressed X-linked 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of BEX2 mRNA
CTD
PMID:36139627
NCBI chr X:99,219,014...99,220,518
Ensembl chr X:99,219,014...99,220,958
G
Bicdl2
BICD family like cargo adaptor 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of BICDL2 mRNA
CTD
PMID:36139627
NCBI chr10:12,691,610...12,700,049
Ensembl chr10:12,691,610...12,700,049
G
Bin2
bridging integrator 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of BIN2 mRNA
CTD
PMID:36139627
NCBI chr 7:131,742,001...131,768,208
Ensembl chr 7:131,742,002...131,786,285
G
Blacat1
BLACAT1 overlapping LEMD1 locus
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of BLACAT1 mRNA
CTD
PMID:36139627
G
Blnk
B-cell linker
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of BLNK mRNA
CTD
PMID:36139627
NCBI chr 1:239,753,640...239,821,113
Ensembl chr 1:239,753,648...239,821,113
G
Bmp6
bone morphogenetic protein 6
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of BMP6 mRNA
CTD
PMID:36139627
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
G
Borcs8
BLOC-1 related complex subunit 8
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of BORCS8 mRNA
CTD
PMID:36139627
NCBI chr16:19,274,305...19,280,969
Ensembl chr16:19,274,023...19,280,339
G
Btc
betacellulin
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of BTC mRNA
CTD
PMID:36139627
NCBI chr14:16,708,447...16,746,961
Ensembl chr14:16,707,982...16,747,049
G
Btg2
BTG anti-proliferation factor 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of BTG2 mRNA
CTD
PMID:36139627
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
C13h1orf116
similar to human chromosome 1 open reading frame 116
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of C1ORF116 mRNA
CTD
PMID:36139627
NCBI chr13:42,187,442...42,201,432
Ensembl chr13:42,188,609...42,201,426
G
C14h7orf57
similar to human chromosome 7 open reading frame 57
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of C7ORF57 mRNA
CTD
PMID:36139627
NCBI chr14:83,748,478...83,768,293
Ensembl chr14:83,748,478...83,767,435
G
C1r
complement C1r
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of C1R mRNA
CTD
PMID:36139627
NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:157,412,692...157,423,484
G
C1s
complement C1s
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of C1S mRNA
CTD
PMID:36139627
NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303
G
C3h15orf48
similar to human chromosome 15 open reading frame 48
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of C15ORF48 mRNA
CTD
PMID:36139627
NCBI chr 3:109,719,952...109,723,505
Ensembl chr 3:109,719,897...109,724,006 Ensembl chr 3:109,719,897...109,724,006
G
C7
complement C7
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of C7 mRNA
CTD
PMID:36139627
NCBI chr 2:54,088,116...54,165,102
Ensembl chr 2:54,088,116...54,158,535
G
Cacna1d
calcium voltage-gated channel subunit alpha1 D
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CACNA1D mRNA
CTD
PMID:36139627
NCBI chr16:5,227,157...5,521,163
Ensembl chr16:5,228,306...5,668,215
G
Cacna1f
calcium voltage-gated channel subunit alpha1 F
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CACNA1F mRNA
CTD
PMID:36139627
NCBI chr X:14,868,096...14,896,413
Ensembl chr X:14,868,024...14,896,413
G
Cacnb4
calcium voltage-gated channel auxiliary subunit beta 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CACNB4 mRNA
CTD
PMID:36139627
NCBI chr 3:36,906,771...37,169,165
Ensembl chr 3:36,910,427...37,168,944
G
Calb2
calbindin 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CALB2 mRNA
CTD
PMID:36139627
NCBI chr19:38,114,435...38,141,438
Ensembl chr19:38,114,424...38,141,438
G
Capn12
calpain 12
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CAPN12 mRNA
CTD
PMID:36139627
NCBI chr 1:84,171,059...84,183,161
Ensembl chr 1:84,171,059...84,183,119
G
Capn8
calpain 8
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CAPN8 mRNA
CTD
PMID:36139627
NCBI chr13:94,252,218...94,316,146
Ensembl chr13:94,253,054...94,316,146
G
Car9
carbonic anhydrase 9
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CA9 mRNA
CTD
PMID:36139627
NCBI chr 5:57,763,234...57,769,838
Ensembl chr 5:57,763,206...57,769,838
G
Casp1
caspase 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CASP1 mRNA
CTD
PMID:36139627
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
G
Casp3
caspase 3
increases cleavage
ISO
sotorasib results in increased cleavage of CASP3 protein
CTD
PMID:31666701
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Catspere
catsper channel auxiliary subunit epsilon
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CATSPERE mRNA
CTD
PMID:36139627
NCBI chr13:89,799,669...89,954,723
Ensembl chr13:89,819,244...89,950,979
G
Ccdc110
coiled-coil domain containing 110
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CCDC110 mRNA
CTD
PMID:36139627
NCBI chr16:46,315,745...46,337,050
Ensembl chr16:46,315,745...46,337,021
G
Ccdc87
coiled-coil domain containing 87
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CCDC87 mRNA
CTD
PMID:36139627
NCBI chr 1:202,135,021...202,137,717
Ensembl chr 1:202,134,963...202,138,337
G
Ccdc89
coiled-coil domain containing 89
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CCDC89 mRNA
CTD
PMID:36139627
NCBI chr 1:144,386,252...144,387,514
Ensembl chr 1:144,386,158...144,389,850
G
Ccdc96
coiled-coil domain containing 96
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CFAP184 mRNA
CTD
PMID:36139627
NCBI chr14:74,276,568...74,279,072
Ensembl chr14:74,276,960...74,278,888
G
Ccl22
C-C motif chemokine ligand 22
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CCL22 mRNA
CTD
PMID:36139627
NCBI chr19:10,257,602...10,264,373
Ensembl chr19:10,257,601...10,264,400
G
Ccm2l
CCM2 like scaffold protein
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CCM2L mRNA
CTD
PMID:36139627
NCBI chr 3:141,533,470...141,549,136
Ensembl chr 3:141,533,511...141,549,140
G
Ccne2
cyclin E2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CCNE2 mRNA
CTD
PMID:36139627
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
G
Ccr1
C-C motif chemokine receptor 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CCR1 mRNA
CTD
PMID:36139627
NCBI chr 8:123,556,286...123,561,841
G
Cd22
CD22 molecule
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CD22 mRNA
CTD
PMID:36139627
NCBI chr 1:86,116,376...86,132,782
Ensembl chr 1:86,117,459...86,132,322
G
Cd274
CD274 molecule
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CD274 mRNA
CTD
PMID:36139627
NCBI chr 1:227,116,674...227,137,379
Ensembl chr 1:227,116,649...227,134,450
G
Cd72
Cd72 molecule
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CD72 mRNA
CTD
PMID:36139627
NCBI chr 5:57,697,361...57,704,980
Ensembl chr 5:57,697,367...57,704,725
G
Cd74
CD74 molecule
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CD74 mRNA
CTD
PMID:36139627
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
G
Cd82
Cd82 molecule
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CD82 mRNA
CTD
PMID:36139627
NCBI chr 3:79,387,361...79,431,847
Ensembl chr 3:79,385,887...79,431,809
G
Cdcp1
CUB domain containing protein 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CDCP1 mRNA
CTD
PMID:36139627
NCBI chr 8:122,828,685...122,865,345
Ensembl chr 8:122,828,685...122,865,388
G
Cdh15
cadherin 15
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CDH15 mRNA
CTD
PMID:36139627
NCBI chr19:50,903,757...50,927,151
Ensembl chr19:50,903,638...50,927,105
G
Cdh3
cadherin 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CDH3 mRNA
CTD
PMID:36139627
NCBI chr19:34,393,596...34,444,084
Ensembl chr19:34,393,727...34,444,084
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CDKN1A mRNA
CTD
PMID:36139627
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CDKN1C mRNA
CTD
PMID:36139627
NCBI chr 1:198,655,394...198,658,097
Ensembl chr 1:198,655,407...198,658,048
G
Cenps
centromere protein S
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CENPS mRNA
CTD
PMID:36139627
NCBI chr 5:159,563,917...159,573,534
G
Cfap45
cilia and flagella associated protein 45
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CFAP45 mRNA
CTD
PMID:36139627
NCBI chr13:84,989,474...85,012,880
Ensembl chr13:84,981,728...85,012,878
G
Cfap92
cilia and flagella associated protein 92
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CFAP92 mRNA
CTD
PMID:36139627
NCBI chr 4:120,126,565...120,181,575
Ensembl chr 4:120,126,567...120,181,546
G
Cfap96
cilia and flagella associated protein 96
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CFAP96 mRNA
CTD
PMID:36139627
NCBI chr16:46,291,075...46,315,616
Ensembl chr16:46,291,311...46,315,625
G
Cfh
complement factor H
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CFH mRNA
CTD
PMID:36139627
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
G
Chd7
chromodomain helicase DNA binding protein 7
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CHD7 mRNA
CTD
PMID:36139627
NCBI chr 5:21,812,007...21,995,358
Ensembl chr 5:21,812,070...21,995,358
G
Chd9nb
CHD9 neighbor
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CHD9NB mRNA
CTD
PMID:36139627
G
Chgb
chromogranin B
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CHGB mRNA
CTD
PMID:36139627
NCBI chr 3:120,043,824...120,057,169
Ensembl chr 3:120,043,738...120,057,166
G
Chrm4
cholinergic receptor, muscarinic 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CHRM4 mRNA
CTD
PMID:36139627
NCBI chr 3:77,893,425...77,901,166
Ensembl chr 3:77,893,425...77,901,159
G
Chrna10
cholinergic receptor nicotinic alpha 10 subunit
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CHRNA10 mRNA
CTD
PMID:36139627
NCBI chr 1:156,487,279...156,494,277
Ensembl chr 1:156,487,279...156,491,476
G
Ciart
circadian associated repressor of transcription
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CIART mRNA
CTD
PMID:36139627
NCBI chr 2:183,419,819...183,424,845
Ensembl chr 2:183,419,819...183,423,313
G
Cimip2a
ciliary microtubule inner protein 2A
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CIMIP2A mRNA
CTD
PMID:36139627
NCBI chr 3:8,030,548...8,038,370
Ensembl chr 3:8,033,246...8,037,961
G
Cldn9
claudin 9
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CLDN9 mRNA
CTD
PMID:36139627
NCBI chr10:12,714,137...12,715,568
G
Cnih2
cornichon family AMPA receptor auxiliary protein 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CNIH2 mRNA
CTD
PMID:36139627
NCBI chr 1:202,399,416...202,405,110
Ensembl chr 1:202,399,419...202,405,089
G
Col13a1
collagen type XIII alpha 1 chain
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of COL13A1 mRNA
CTD
PMID:36139627
NCBI chr20:29,783,965...29,924,116
Ensembl chr20:29,783,965...29,924,032
G
Col1a2
collagen type I alpha 2 chain
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of COL1A2 mRNA
CTD
PMID:36139627
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
G
Col5a3
collagen type V alpha 3 chain
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of COL5A3 mRNA
CTD
PMID:36139627
NCBI chr 8:19,304,564...19,349,809
Ensembl chr 8:19,304,571...19,349,853
G
Col6a3
collagen type VI alpha 3 chain
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of COL6A3 mRNA
CTD
PMID:36139627
NCBI chr 9:91,361,578...91,439,434
Ensembl chr 9:91,361,583...91,439,471
G
Col9a2
collagen type IX alpha 2 chain
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of COL9A2 mRNA
CTD
PMID:36139627
NCBI chr 5:134,607,616...134,624,678
Ensembl chr 5:134,607,616...134,624,677
G
Colq
collagen like tail subunit of asymmetric acetylcholinesterase
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of COLQ mRNA
CTD
PMID:36139627
NCBI chr16:6,731,850...6,824,973
Ensembl chr16:6,731,858...6,787,107
G
Cpe
carboxypeptidase E
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CPE mRNA
CTD
PMID:36139627
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
G
Cracr2b
calcium release activated channel regulator 2B
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CRACR2B mRNA
CTD
PMID:36139627
NCBI chr 1:196,558,407...196,563,961
Ensembl chr 1:196,558,588...196,563,771
G
Creb3l1
cAMP responsive element binding protein 3-like 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CREB3L1 mRNA
CTD
PMID:36139627
NCBI chr 3:77,952,589...77,993,513
Ensembl chr 3:77,952,540...77,993,456
G
Creb3l3
cAMP responsive element binding protein 3-like 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CREB3L3 mRNA
CTD
PMID:36139627
NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:8,622,614...8,631,048
G
Creg2
cellular repressor of E1A-stimulated genes 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CREG2 mRNA
CTD
PMID:36139627
NCBI chr 9:41,872,000...41,945,413
Ensembl chr 9:41,902,304...41,945,095
G
Crybg1
crystallin beta-gamma domain containing 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CRYBG1 mRNA
CTD
PMID:36139627
NCBI chr20:47,425,030...47,496,918
Ensembl chr20:47,426,183...47,621,392
G
Crym
crystallin, mu
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CRYM mRNA
CTD
PMID:36139627
NCBI chr 1:174,560,423...174,575,660
Ensembl chr 1:174,560,416...174,575,633
G
Csad
cysteine sulfinic acid decarboxylase
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CSAD mRNA
CTD
PMID:36139627
NCBI chr 7:133,308,571...133,337,914
Ensembl chr 7:133,308,574...133,337,615
G
Csf3
colony stimulating factor 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CSF3 mRNA
CTD
PMID:36139627
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
G
Ctsc
cathepsin C
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CTSC mRNA
CTD
PMID:36139627
NCBI chr 1:142,028,386...142,059,841
Ensembl chr 1:142,028,392...142,060,387
G
Ctsl
cathepsin L
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CTSL mRNA
CTD
PMID:36139627
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
G
Ctso
cathepsin O
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CTSO mRNA
CTD
PMID:36139627
NCBI chr 2:167,230,407...167,254,761
Ensembl chr 2:167,230,330...167,253,702
G
Cx3cl1
C-X3-C motif chemokine ligand 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CX3CL1 mRNA
CTD
PMID:36139627
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cxcl10
C-X-C motif chemokine ligand 10
increases expression
ISO
sotorasib results in increased expression of CXCL10 mRNA
CTD
PMID:31666701
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
G
Cxcl11
C-X-C motif chemokine ligand 11
increases expression
ISO
sotorasib results in increased expression of CXCL11 mRNA
CTD
PMID:31666701
NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,689,424...15,692,271
G
Cyp26b1
cytochrome P450, family 26, subfamily b, polypeptide 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of CYP26B1 mRNA
CTD
PMID:36139627
NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
G
Ddit4l
DNA-damage-inducible transcript 4-like
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of DDIT4L mRNA
CTD
PMID:36139627
NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375
G
Ddx60
DEXD/H-box helicase 60
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of DDX60 mRNA
CTD
PMID:36139627
NCBI chr16:28,077,000...28,197,903
Ensembl chr16:28,076,999...28,179,526
G
Dennd3
DENN domain containing 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of DENND3 mRNA
CTD
PMID:36139627
NCBI chr 7:105,415,870...105,473,583
Ensembl chr 7:105,415,677...105,473,592
G
Depp1
DEPP autophagy regulator 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of DEPP1 mRNA
CTD
PMID:36139627
NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542
G
Deptor
DEP domain containing MTOR-interacting protein
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of DEPTOR mRNA
CTD
PMID:36139627
NCBI chr 7:86,514,859...86,668,817
Ensembl chr 7:86,514,988...86,667,773
G
Dhrs2
dehydrogenase/reductase 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of DHRS2 mRNA
CTD
PMID:36139627
NCBI chr15:28,688,881...28,703,646
Ensembl chr15:28,688,940...28,703,644
G
Dio2
iodothyronine deiodinase 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of DIO2 mRNA
CTD
PMID:36139627
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
G
Dkk3
dickkopf WNT signaling pathway inhibitor 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of DKK3 mRNA
CTD
PMID:36139627
NCBI chr 1:166,237,969...166,281,271
Ensembl chr 1:166,238,238...166,280,590
G
Dlc1
DLC1 Rho GTPase activating protein
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of DLC1 mRNA
CTD
PMID:36139627
NCBI chr16:55,246,716...55,671,441
Ensembl chr16:55,291,584...55,671,439
G
Dmkn
dermokine
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of DMKN mRNA
CTD
PMID:36139627
NCBI chr 1:86,013,237...86,031,243
Ensembl chr 1:86,014,188...86,030,006
G
Dnaaf8
dynein axonemal assembly factor 8
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of DNAAF8 mRNA
CTD
PMID:36139627
NCBI chr10:10,600,747...10,614,891
Ensembl chr10:10,600,734...10,614,891
G
Dnah11
dynein, axonemal, heavy chain 11
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of DNAH11 mRNA
CTD
PMID:36139627
NCBI chr 6:138,839,175...139,155,554
Ensembl chr 6:138,839,177...139,155,536
G
Doc2b
double C2 domain beta
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of DOC2B mRNA
CTD
PMID:36139627
NCBI chr10:60,628,029...60,653,267
Ensembl chr10:60,628,029...60,653,267
G
Dok3
docking protein 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of DOK3 mRNA
CTD
PMID:36139627
NCBI chr17:9,109,633...9,115,188
Ensembl chr17:9,109,597...9,115,188
G
Drc3
dynein regulatory complex subunit 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of DRC3 mRNA
CTD
PMID:36139627
NCBI chr10:45,149,094...45,200,659
Ensembl chr10:45,157,354...45,199,369
G
Duox1
dual oxidase 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of DUOX1 mRNA
CTD
PMID:36139627
NCBI chr 3:109,260,526...109,295,588
Ensembl chr 3:109,262,397...109,295,563
G
Duox2
dual oxidase 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of DUOX2 mRNA
CTD
PMID:36139627
NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902
G
Duoxa1
dual oxidase maturation factor 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of DUOXA1 mRNA
CTD
PMID:36139627
NCBI chr 3:109,249,815...109,260,511
Ensembl chr 3:109,249,923...109,260,499
G
Dusp4
dual specificity phosphatase 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of DUSP4 mRNA
CTD
PMID:36139627
NCBI chr16:57,376,659...57,398,161
Ensembl chr16:57,377,229...57,398,138
G
Dusp5
dual specificity phosphatase 5
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of DUSP5 mRNA
CTD
PMID:36139627
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
G
Dusp6
dual specificity phosphatase 6
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of DUSP6 mRNA
CTD
PMID:36139627
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
E2f2
E2F transcription factor 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of E2F2 mRNA
CTD
PMID:36139627
NCBI chr 5:148,399,193...148,422,595
Ensembl chr 5:148,399,642...148,421,217
G
E2f7
E2F transcription factor 7
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of E2F7 mRNA
CTD
PMID:36139627
NCBI chr 7:46,150,533...46,192,739
Ensembl chr 7:46,151,293...46,192,734
G
Efemp2
EGF containing fibulin extracellular matrix protein 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of EFEMP2 mRNA
CTD
PMID:36139627
NCBI chr 1:202,781,692...202,789,784
Ensembl chr 1:202,781,665...202,789,414
G
Efna3
ephrin A3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of EFNA3 mRNA
CTD
PMID:36139627
NCBI chr 2:174,729,192...174,738,111
Ensembl chr 2:174,729,764...174,738,736
G
Egf
epidermal growth factor
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of EGF mRNA
CTD
PMID:36139627
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Egfr
epidermal growth factor receptor
increases phosphorylation
ISO
sotorasib results in increased phosphorylation of EGFR protein
CTD
PMID:31666701
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
G
Eif4e3
eukaryotic translation initiation factor 4E family member 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of EIF4E3 mRNA
CTD
PMID:36139627
NCBI chr 4:132,258,502...132,301,808
Ensembl chr 4:132,258,502...132,301,808
G
Elf5
E74 like ETS transcription factor 5
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ELF5 mRNA
CTD
PMID:36139627
NCBI chr 3:89,808,837...89,836,977
Ensembl chr 3:89,797,880...89,836,973
G
Elmod1
ELMO domain containing 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ELMOD1 mRNA
CTD
PMID:36139627
NCBI chr 8:54,298,363...54,355,348
Ensembl chr 8:54,298,363...54,355,140
G
Eno2
enolase 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ENO2 mRNA
CTD
PMID:36139627
NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980
G
Eno4
enolase 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ENO4 mRNA
CTD
PMID:36139627
NCBI chr 1:258,096,406...258,119,811
Ensembl chr 1:258,096,432...258,128,984
G
Enpp1
ectonucleotide pyrophosphatase/phosphodiesterase 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ENPP1 mRNA
CTD
PMID:36139627
NCBI chr 1:20,698,746...20,763,741
Ensembl chr 1:20,698,764...20,763,715
G
Entpd2
ectonucleoside triphosphate diphosphohydrolase 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ENTPD2 mRNA
CTD
PMID:36139627
NCBI chr 3:8,213,575...8,219,094
Ensembl chr 3:8,213,663...8,226,866
G
Epas1
endothelial PAS domain protein 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of EPAS1 mRNA
CTD
PMID:36139627
NCBI chr 6:7,790,236...7,871,717
Ensembl chr 6:7,790,647...7,871,228
G
Epha3
Eph receptor A3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of EPHA3 mRNA
CTD
PMID:36139627
NCBI chr11:1,138,485...1,474,102
Ensembl chr11:1,140,985...1,473,900
G
Epha8
Eph receptor A8
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of EPHA8 mRNA
CTD
PMID:36139627
NCBI chr 5:149,166,107...149,193,515
Ensembl chr 5:149,166,697...149,193,399
G
Eppk1
epiplakin 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of EPPK1 mRNA
CTD
PMID:36139627
NCBI chr 7:107,816,919...107,842,946
Ensembl chr 7:107,817,693...107,831,159
G
Erap1
endoplasmic reticulum aminopeptidase 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ERAP1 mRNA
CTD
PMID:36139627
NCBI chr 2:3,931,817...3,970,735
Ensembl chr 2:3,931,904...3,972,447
G
Erfl
ETS repressor factor like
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ERFL mRNA
CTD
PMID:36139627
NCBI chr 1:80,521,378...80,526,262
Ensembl chr 1:80,521,854...80,526,262
G
Ero1a
endoplasmic reticulum oxidoreductase 1 alpha
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ERO1A mRNA
CTD
PMID:36139627
NCBI chr15:18,495,037...18,530,440
Ensembl chr15:18,492,945...18,530,478
G
Esrp1
epithelial splicing regulatory protein 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ESRP1 mRNA
CTD
PMID:36139627
NCBI chr 5:24,427,611...24,482,157
Ensembl chr 5:24,428,717...24,482,062
G
Etv2
ETS variant transcription factor 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ETV2 mRNA
CTD
PMID:36139627
NCBI chr 1:85,890,562...85,894,025
Ensembl chr 1:85,890,559...85,893,431
G
Etv4
ETS variant transcription factor 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ETV4 mRNA
CTD
PMID:36139627
NCBI chr10:86,706,749...86,721,974
Ensembl chr10:86,706,749...86,721,974
G
Evi2a
ecotropic viral integration site 2A
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of EVI2A mRNA
CTD
PMID:36139627
NCBI chr10:64,485,760...64,489,660
Ensembl chr10:64,485,200...64,489,843
G
Exoc3l1
exocyst complex component 3-like 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of EXOC3L1 mRNA
CTD
PMID:36139627
NCBI chr19:33,166,836...33,174,371
Ensembl chr19:33,166,837...33,172,486
G
Exoc3l4
exocyst complex component 3-like 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of EXOC3L4 mRNA
CTD
PMID:36139627
NCBI chr 6:130,452,680...130,466,684
Ensembl chr 6:130,452,661...130,466,683
G
Exph5
exophilin 5
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of EXPH5 mRNA
CTD
PMID:36139627
NCBI chr 8:53,698,825...53,775,371
Ensembl chr 8:53,698,852...53,773,169
G
F2rl1
F2R like trypsin receptor 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of F2RL1 mRNA
CTD
PMID:36139627
NCBI chr 2:26,772,274...26,785,226
Ensembl chr 2:26,772,278...26,785,226
G
Fam107b
family with sequence similarity 107, member B
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of FAM107B mRNA
CTD
PMID:36139627
NCBI chr17:74,478,608...74,685,027
Ensembl chr17:74,478,608...74,684,989
G
Fam186b
family with sequence similarity 186, member B
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of FAM186B mRNA
CTD
PMID:36139627
NCBI chr 7:130,408,830...130,424,261
Ensembl chr 7:130,408,830...130,424,261
G
Fam241a
family with sequence similarity 241 member A
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of FAM241A mRNA
CTD
PMID:36139627
NCBI chr 2:216,344,563...216,375,193
Ensembl chr 2:216,343,822...216,375,242
G
Fat2
FAT atypical cadherin 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of FAT2 mRNA
CTD
PMID:36139627
NCBI chr10:39,364,072...39,456,324
Ensembl chr10:39,364,073...39,456,216
G
Fbxo36
F-box protein 36
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of FBXO36 mRNA
CTD
PMID:36139627
NCBI chr 9:86,042,522...86,107,220
Ensembl chr 9:86,040,862...86,107,229
G
Fdxr
ferredoxin reductase
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of FDXR mRNA
CTD
PMID:36139627
NCBI chr10:100,507,863...100,516,649
Ensembl chr10:100,507,865...100,516,658
G
Fgf19
fibroblast growth factor 19
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of FGF19 mRNA
CTD
PMID:36139627
NCBI chr 1:200,056,526...200,060,980
Ensembl chr 1:200,056,644...200,060,287
G
Fhip1a
FHF complex subunit HOOK interacting protein 1A
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of FHIP1A mRNA
CTD
PMID:36139627
NCBI chr 2:171,016,951...171,265,715
Ensembl chr 2:171,021,246...171,265,848
G
Flacc1
flagellum associated containing coiled-coil domains 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of FLACC1 mRNA
CTD
PMID:36139627
NCBI chr 9:60,315,581...60,343,692
Ensembl chr 9:60,315,582...60,343,648
G
Flnc
filamin C
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of FLNC mRNA
CTD
PMID:36139627
NCBI chr 4:58,034,088...58,061,882
Ensembl chr 4:58,034,189...58,061,844
G
Fmn1
formin 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of FMN1 mRNA
CTD
PMID:36139627
NCBI chr 3:100,101,103...100,485,652
Ensembl chr 3:100,134,549...100,479,220
G
Fndc11
fibronectin type III domain containing 11
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of FNDC11 mRNA
CTD
PMID:36139627
NCBI chr 3:168,330,607...168,333,111
Ensembl chr 3:168,330,602...168,334,617
G
Foxd4
forkhead box D4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of FOXD4 mRNA
CTD
PMID:36139627
NCBI chr 1:222,557,494...222,559,189
Ensembl chr 1:222,557,360...222,559,159
G
Foxq1
forkhead box Q1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of FOXQ1 mRNA
CTD
PMID:36139627
NCBI chr17:32,912,744...32,915,377
Ensembl chr17:32,912,744...32,915,377 Ensembl chr17:32,912,744...32,915,377
G
Frmd4b
FERM domain containing 4B
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of FRMD4B mRNA
CTD
PMID:36139627
NCBI chr 4:129,895,401...130,222,070
Ensembl chr 4:129,895,708...130,084,197
G
Fscn1
fascin actin-bundling protein 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of FSCN1 mRNA
CTD
PMID:36139627
NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211
G
Fut11
fucosyltransferase 11
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of FUT11 mRNA
CTD
PMID:36139627
NCBI chr15:3,598,768...3,602,328
Ensembl chr15:3,598,758...3,602,356
G
Fyb2
FYN binding protein 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of FYB2 mRNA
CTD
PMID:36139627
NCBI chr 5:119,677,116...119,800,911
Ensembl chr 5:119,677,204...119,800,910
G
Gab2
GRB2-associated binding protein 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GAB2 mRNA
CTD
PMID:36139627
NCBI chr 1:151,429,844...151,625,708
Ensembl chr 1:151,429,695...151,625,031
G
Gad1
glutamate decarboxylase 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GAD1 mRNA
CTD
PMID:36139627
NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333
G
Gal3st1
galactose-3-O-sulfotransferase 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GAL3ST1 mRNA
CTD
PMID:36139627
NCBI chr14:78,868,049...78,886,402
Ensembl chr14:78,870,793...78,886,388
G
Galnt7
polypeptide N-acetylgalactosaminyltransferase 7
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of GALNT7 mRNA
CTD
PMID:36139627
NCBI chr16:32,578,643...32,703,189
Ensembl chr16:32,578,690...32,702,690
G
Gas6
growth arrest specific 6
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of GAS6 mRNA
CTD
PMID:36139627
NCBI chr16:76,045,430...76,075,904
Ensembl chr16:76,045,426...76,075,904
G
Gask1b
golgi associated kinase 1B
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GASK1B mRNA
CTD
PMID:36139627
NCBI chr 2:165,047,689...165,112,479
Ensembl chr 2:165,047,684...165,112,477
G
Gbp2
guanylate binding protein 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GBP2 mRNA
CTD
PMID:36139627
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
G
Gckr
glucokinase regulator
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GCKR mRNA
CTD
PMID:36139627
NCBI chr 6:25,044,592...25,075,834
Ensembl chr 6:25,045,100...25,075,654
G
Gcnt3
glucosaminyl (N-acetyl) transferase 3, mucin type
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GCNT3 mRNA
CTD
PMID:36139627
NCBI chr 8:70,689,173...70,696,476
Ensembl chr 8:70,686,844...70,699,562
G
Gdap1
ganglioside-induced differentiation-associated-protein 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of GDAP1 mRNA
CTD
PMID:36139627
NCBI chr 5:1,932,613...1,951,691
Ensembl chr 5:1,932,613...2,030,061
G
Ghr
growth hormone receptor
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of GHR mRNA
CTD
PMID:36139627
NCBI chr 2:52,541,452...52,804,960
Ensembl chr 2:52,542,594...52,804,735
G
Gipc3
GIPC PDZ domain containing family, member 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GIPC3 mRNA
CTD
PMID:36139627
NCBI chr 7:8,374,941...8,383,281
G
Gipr
gastric inhibitory polypeptide receptor
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GIPR mRNA
CTD
PMID:36139627
NCBI chr 1:78,804,287...78,814,462
Ensembl chr 1:78,805,593...78,814,462
G
Gjb3
gap junction protein, beta 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GJB3 mRNA
CTD
PMID:36139627
NCBI chr 5:139,649,227...139,654,970
Ensembl chr 5:139,649,195...139,654,980
G
Gjb4
gap junction protein, beta 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GJB4 mRNA
CTD
PMID:36139627
NCBI chr 5:139,675,776...139,679,551
Ensembl chr 5:139,675,780...139,679,667
G
Gldc
glycine decarboxylase
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GLDC mRNA
CTD
PMID:36139627
NCBI chr 1:227,883,249...227,962,119
Ensembl chr 1:227,883,249...227,962,097
G
Glul
glutamate-ammonia ligase
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GLUL mRNA
CTD
PMID:36139627
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
G
Gpnmb
glycoprotein nmb
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GPNMB mRNA
CTD
PMID:36139627
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
G
Gpr146
G protein-coupled receptor 146
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GPR146 mRNA
CTD
PMID:36139627
NCBI chr12:15,251,936...15,267,217
Ensembl chr12:15,251,813...15,267,206
G
Gpr37l1
G protein-coupled receptor 37-like 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of GPR37L1 mRNA
CTD
PMID:36139627
NCBI chr13:46,598,574...46,605,421
Ensembl chr13:46,598,578...46,605,421
G
Gpr39
G protein-coupled receptor 39
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of GPR39 mRNA
CTD
PMID:36139627
NCBI chr13:37,115,258...37,327,312
Ensembl chr13:37,115,102...37,328,267
G
Gpr87
G protein-coupled receptor 87
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GPR87 mRNA
CTD
PMID:36139627
NCBI chr 2:143,439,741...143,440,901
Ensembl chr 2:143,439,735...143,458,190
G
Gramd1b
GRAM domain containing 1B
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GRAMD1B mRNA
CTD
PMID:36139627
NCBI chr 8:40,654,492...40,893,869
Ensembl chr 8:40,659,182...40,893,925
G
Grb7
growth factor receptor bound protein 7
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GRB7 mRNA
CTD
PMID:36139627
NCBI chr10:83,443,387...83,453,057
Ensembl chr10:83,444,004...83,453,052
G
Grin2d
glutamate ionotropic receptor NMDA type subunit 2D
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GRIN2D mRNA
CTD
PMID:36139627
NCBI chr 1:96,306,871...96,346,994
Ensembl chr 1:96,308,365...96,344,793
G
Gsdmc
gasdermin C
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of GSDMC mRNA
CTD
PMID:36139627
NCBI chr 7:95,594,015...95,606,106
Ensembl chr 7:95,594,015...95,611,344
G
Gtf2ird2
GTF2I repeat domain containing 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of GTF2IRD2 mRNA
CTD
PMID:36139627
NCBI chr12:22,497,767...22,536,455
Ensembl chr12:22,498,091...22,536,263
G
Guca1b
guanylate cyclase activator 1B
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of GUCA1B mRNA
CTD
PMID:36139627
NCBI chr 9:13,599,619...13,607,455
Ensembl chr 9:13,599,619...13,607,455
G
H1f2
H1.2 linker histone, cluster member
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of H1-2 mRNA
CTD
PMID:36139627
NCBI chr17:41,391,106...41,392,597
Ensembl chr17:41,388,477...41,392,635
G
Hal
histidine ammonia lyase
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of HAL mRNA
CTD
PMID:36139627
NCBI chr 7:28,007,449...28,037,701
Ensembl chr 7:28,006,972...28,037,701
G
Hapln2
hyaluronan and proteoglycan link protein 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HAPLN2 mRNA
CTD
PMID:36139627
NCBI chr 2:173,488,909...173,496,824
Ensembl chr 2:173,491,160...173,496,588
G
Has3
hyaluronan synthase 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of HAS3 mRNA
CTD
PMID:36139627
NCBI chr19:34,768,421...34,782,170
Ensembl chr19:34,771,982...34,782,592
G
Hbegf
heparin-binding EGF-like growth factor
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HBEGF mRNA
CTD
PMID:36139627
NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441
G
Hecw2
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of HECW2 mRNA
CTD
PMID:36139627
NCBI chr 9:55,359,462...55,753,106
Ensembl chr 9:55,365,203...55,580,327
G
Herc6
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of HERC6 mRNA
CTD
PMID:36139627
NCBI chr 4:87,524,470...87,566,895
Ensembl chr 4:87,524,493...87,581,744
G
Hey1
hes-related family bHLH transcription factor with YRPW motif 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of HEY1 mRNA
CTD
PMID:36139627
NCBI chr 2:93,096,605...93,100,316
Ensembl chr 2:93,095,498...93,100,312
G
Heyl
hes-related family bHLH transcription factor with YRPW motif-like
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HEYL mRNA
CTD
PMID:36139627
NCBI chr 5:135,508,160...135,525,152
Ensembl chr 5:135,508,160...135,525,152
G
Hic1
HIC ZBTB transcriptional repressor 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HIC1 mRNA
CTD
PMID:36139627
NCBI chr10:60,014,520...60,019,475
Ensembl chr10:60,011,528...60,019,475
G
Hilpda
hypoxia inducible lipid droplet-associated
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HILPDA mRNA
CTD
PMID:36139627
NCBI chr 4:57,871,088...57,874,048
Ensembl chr 4:57,871,110...57,874,557
G
Hist1h2ah
histone cluster 1 H2A family member H
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of H2AC11 mRNA
CTD
PMID:36139627
NCBI chr17:41,384,521...41,385,018
G
Hist1h2al1
histone cluster 1 H2A family like 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of H2AC6 mRNA
CTD
PMID:36139627
NCBI chr17:42,707,954...42,708,420
G
Hivep2
HIVEP zinc finger 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HIVEP2 mRNA
CTD
PMID:36139627
NCBI chr 1:8,358,205...8,555,993
Ensembl chr 1:8,359,289...8,555,993
G
Hk2
hexokinase 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HK2 mRNA
CTD
PMID:36139627
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
G
Hkdc1
hexokinase domain containing 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HKDC1 mRNA
CTD
PMID:36139627
NCBI chr20:30,335,322...30,373,792
Ensembl chr20:30,335,628...30,373,867
G
Hoga1
4-hydroxy-2-oxoglutarate aldolase 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of HOGA1 mRNA
CTD
PMID:36139627
NCBI chr 1:240,856,991...240,884,243
Ensembl chr 1:240,857,126...240,884,568
G
Hoxa13
homeo box A13
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HOXA13 mRNA
CTD
PMID:36139627
NCBI chr 4:81,358,956...81,361,091
Ensembl chr 4:81,358,956...81,361,091
G
Hoxb9
homeo box B9
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HOXB9 mRNA
CTD
PMID:36139627
NCBI chr10:81,237,312...81,240,818
Ensembl chr10:81,237,312...81,240,818
G
Hoxc4
homeo box C4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of HOXC4 mRNA
CTD
PMID:36139627
NCBI chr 7:134,135,279...134,173,133
Ensembl chr 7:134,170,591...134,173,133
G
Hpcal4
hippocalcin-like 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HPCAL4 mRNA
CTD
PMID:36139627
NCBI chr 5:135,454,477...135,466,417
Ensembl chr 5:135,454,540...135,466,416
G
Hs3st3b1
heparan sulfate-glucosamine 3-sulfotransferase 3B1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HS3ST3B1 mRNA
CTD
PMID:36139627
NCBI chr10:48,561,473...48,593,970
Ensembl chr10:48,561,473...48,593,970
G
Hsd17b14
hydroxysteroid (17-beta) dehydrogenase 14
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HSD17B14 mRNA
CTD
PMID:36139627
NCBI chr 1:96,029,224...96,039,577
Ensembl chr 1:96,029,284...96,039,883
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of HSPA1A mRNA
CTD
PMID:36139627
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Htra1
HtrA serine peptidase 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of HTRA1 mRNA
CTD
PMID:36139627
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
G
Hunk
hormonally upregulated Neu-associated kinase
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of HUNK mRNA
CTD
PMID:36139627
NCBI chr11:29,641,122...29,758,392
Ensembl chr11:29,640,775...29,757,526
G
Hyal1
hyaluronidase 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of HYAL1 mRNA
CTD
PMID:36139627
NCBI chr 8:108,250,668...108,254,519
Ensembl chr 8:108,250,667...108,260,210
G
Ifi35
interferon-induced protein 35
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of IFI35 mRNA
CTD
PMID:36139627
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
G
Ifnlr1
interferon, lambda receptor 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of IFNLR1 mRNA
CTD
PMID:36139627
NCBI chr 5:147,919,547...147,942,328
Ensembl chr 5:147,919,908...147,942,332
G
Igf2bp3
insulin-like growth factor 2 mRNA binding protein 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of IGF2BP3 mRNA
CTD
PMID:36139627
NCBI chr 4:78,060,494...78,195,007
Ensembl chr 4:78,060,494...78,194,865
G
Igfbp1
insulin-like growth factor binding protein 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of IGFBP1 mRNA
CTD
PMID:36139627
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of IL1B mRNA
CTD
PMID:36139627
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il1rapl1
interleukin 1 receptor accessory protein-like 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of IL1RAPL1 mRNA
CTD
PMID:36139627
NCBI chr X:51,371,969...52,876,726
Ensembl chr X:51,378,215...52,876,772
G
Il6r
interleukin 6 receptor
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of IL6R mRNA
CTD
PMID:36139627
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
G
Inka1
inka box actin regulator 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of INKA1 mRNA
CTD
PMID:36139627
NCBI chr 8:108,674,263...108,675,953
Ensembl chr 8:108,674,263...108,675,953
G
Inpp5d
inositol polyphosphate-5-phosphatase D
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of INPP5D mRNA
CTD
PMID:36139627
NCBI chr 9:88,287,680...88,392,748
Ensembl chr 9:88,287,677...88,392,746
G
Insyn1
inhibitory synaptic factor 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of INSYN1 mRNA
CTD
PMID:36139627
NCBI chr 8:58,904,153...58,914,850
Ensembl chr 8:58,904,153...58,914,843
G
Iqank1
IQ motif and ankyrin repeat containing 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of IQANK1 mRNA
CTD
PMID:36139627
NCBI chr 7:107,724,962...107,759,163
Ensembl chr 7:107,724,997...107,759,162
G
Iqcn
IQ motif containing N
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of IQCN mRNA
CTD
PMID:36139627
NCBI chr16:18,716,519...18,733,971
Ensembl chr16:18,716,519...18,726,261
G
Irak2
interleukin-1 receptor-associated kinase 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of IRAK2 mRNA
CTD
PMID:36139627
NCBI chr 4:146,786,004...146,842,615
Ensembl chr 4:146,786,100...146,842,602
G
Irf1
interferon regulatory factor 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of IRF1 mRNA
CTD
PMID:36139627
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
G
Ism2
isthmin 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ISM2 mRNA
CTD
PMID:36139627
NCBI chr 6:106,921,213...106,944,291
Ensembl chr 6:106,926,175...106,944,514
G
Itga10
integrin subunit alpha 10
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ITGA10 mRNA
CTD
PMID:36139627
NCBI chr 2:184,182,869...184,202,172
Ensembl chr 2:184,182,869...184,202,172
G
Itga2
integrin subunit alpha 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ITGA2 mRNA
CTD
PMID:36139627
NCBI chr 2:46,520,345...46,621,487
Ensembl chr 2:46,523,948...46,621,481
G
Itgax
integrin subunit alpha X
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ITGAX mRNA
CTD
PMID:36139627
NCBI chr 1:182,709,653...182,740,709
Ensembl chr 1:182,719,609...182,740,698
G
Itgb3
integrin subunit beta 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ITGB3 mRNA
CTD
PMID:36139627
NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679
G
Itgb4
integrin subunit beta 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ITGB4 mRNA
CTD
PMID:36139627
NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012
G
Jak3
Janus kinase 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of JAK3 mRNA
CTD
PMID:36139627
NCBI chr16:18,386,330...18,398,542
Ensembl chr16:18,386,405...18,398,536
G
Jam2
junctional adhesion molecule 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of JAM2 mRNA
CTD
PMID:36139627
NCBI chr11:23,830,820...23,880,071
Ensembl chr11:23,831,106...23,880,063
G
Kcnj4
potassium inwardly-rectifying channel, subfamily J, member 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of KCNJ4 mRNA
CTD
PMID:36139627
NCBI chr 7:111,047,097...111,074,151
Ensembl chr 7:111,047,094...111,074,151
G
Kcnk5
potassium two pore domain channel subfamily K member 5
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of KCNK5 mRNA
CTD
PMID:36139627
NCBI chr15:4,122,442...4,164,718
Ensembl chr15:4,122,442...4,164,718
G
Kdm7a
lysine demethylase 7A
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of KDM7A mRNA
CTD
PMID:36139627
NCBI chr 4:67,899,407...67,974,264
Ensembl chr 4:67,904,307...67,966,998
G
Kiaa1755
KIAA1755 ortholog
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of KIAA1755 mRNA
CTD
PMID:36139627
NCBI chr 3:146,850,558...146,884,238
Ensembl chr 3:146,850,557...146,884,871
G
Kif17
kinesin family member 17
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of KIF17 mRNA
CTD
PMID:36139627
NCBI chr 5:150,482,288...150,521,471
Ensembl chr 5:150,481,578...150,519,638
G
Klf7
KLF transcription factor 7
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of KLF7 mRNA
CTD
PMID:36139627
NCBI chr 9:65,433,683...65,526,372
Ensembl chr 9:65,437,167...65,526,261
G
Klhdc7a
kelch domain containing 7A
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of KLHDC7A mRNA
CTD
PMID:36139627
NCBI chr 5:152,218,604...152,224,707
Ensembl chr 5:152,221,033...152,224,551
G
Klhdc7b
kelch domain containing 7B
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of KLHDC7B mRNA
CTD
PMID:36139627
NCBI chr 7:120,452,081...120,455,737
Ensembl chr 7:120,453,932...120,455,737
G
Kras
KRAS proto-oncogene, GTPase
increases response to substance affects binding multiple interactions
ISO
KRAS protein mutant form results in increased susceptibility to sotorasib sotorasib binds to KRAS protein mutant form KRAS protein affects the reaction [sotorasib results in decreased phosphorylation of MAPK1 protein]; KRAS protein affects the reaction [sotorasib results in decreased phosphorylation of MAPK3 protein]
CTD
PMID:31666701
NCBI chr 4:178,185,418...178,218,484
G
Krt15
keratin 15
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of KRT15 mRNA
CTD
PMID:36139627
NCBI chr10:85,066,797...85,070,614
Ensembl chr10:85,066,802...85,171,799
G
Krt7
keratin 7
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of KRT7 mRNA
CTD
PMID:36139627
NCBI chr 7:132,528,881...132,545,052
Ensembl chr 7:132,528,895...132,545,052
G
Krt86
keratin 86
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of KRT86 mRNA
CTD
PMID:36139627
NCBI chr 7:132,591,489...132,598,142
Ensembl chr 7:132,591,545...132,598,021
G
Lad1
ladinin 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LAD1 mRNA
CTD
PMID:36139627
NCBI chr13:47,249,605...47,263,967
Ensembl chr13:47,249,605...47,263,967
G
Lama2
laminin subunit alpha 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LAMA2 mRNA
CTD
PMID:36139627
NCBI chr 1:17,672,675...18,320,641
Ensembl chr 1:17,672,536...18,320,530
G
Lama4
laminin subunit alpha 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LAMA4 mRNA
CTD
PMID:36139627
NCBI chr20:42,392,268...42,533,347
Ensembl chr20:42,392,268...42,533,347
G
Lamc2
laminin subunit gamma 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LAMC2 mRNA
CTD
PMID:36139627
NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200
G
Laptm5
lysosomal protein transmembrane 5
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LAPTM5 mRNA
CTD
PMID:36139627
NCBI chr 5:143,087,759...143,109,807
Ensembl chr 5:143,087,759...143,109,807
G
Lat2
linker for activation of T cells family, member 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LAT2 mRNA
CTD
PMID:36139627
NCBI chr12:22,104,173...22,118,294
Ensembl chr12:22,104,219...22,118,288
G
Lcp1
lymphocyte cytosolic protein 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LCP1 mRNA
CTD
PMID:36139627
NCBI chr15:50,443,300...50,544,682
Ensembl chr15:50,488,149...50,544,680
G
Ldlr
low density lipoprotein receptor
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LDLR mRNA
CTD
PMID:36139627
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Ldlrad1
low density lipoprotein receptor class A domain containing 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LDLRAD1 mRNA
CTD
PMID:36139627
NCBI chr 5:121,984,245...122,000,941
Ensembl chr 5:121,991,690...122,000,944
G
Ldlrad4
low density lipoprotein receptor class A domain containing 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LDLRAD4 mRNA
CTD
PMID:36139627
NCBI chr18:61,519,253...61,848,403
Ensembl chr18:61,521,428...61,843,238
G
Lemd1
LEM domain containing 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LEMD1 mRNA
CTD
PMID:36139627
NCBI chr13:43,631,705...43,697,765
Ensembl chr13:43,665,926...43,697,948
G
Lgals9
galectin 9
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LGALS9 mRNA
CTD
PMID:36139627
NCBI chr10:63,907,018...63,930,224
Ensembl chr10:63,907,018...63,930,045
G
Lgi3
leucine-rich repeat LGI family, member 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LGI3 mRNA
CTD
PMID:36139627
NCBI chr15:45,605,611...45,612,739
Ensembl chr15:45,605,611...45,612,739
G
Lhx1
LIM homeobox 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LHX1 mRNA
CTD
PMID:36139627
NCBI chr10:69,396,829...69,403,617
Ensembl chr10:69,396,829...69,403,617
G
Lhx6
LIM homeobox 6
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LHX6 mRNA
CTD
PMID:36139627
NCBI chr 3:19,432,439...19,456,268
Ensembl chr 3:19,433,494...19,456,061
G
Lipg
lipase G, endothelial type
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LIPG mRNA
CTD
PMID:36139627
NCBI chr18:68,514,923...68,536,105
Ensembl chr18:68,514,923...68,536,260
G
Liph
lipase H
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LIPH mRNA
CTD
PMID:36139627
NCBI chr11:79,032,229...79,081,625
Ensembl chr11:79,033,312...79,081,625
G
Lonrf3
LON peptidase N-terminal domain and ring finger 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LONRF3 mRNA
CTD
PMID:36139627
NCBI chr X:115,565,214...115,603,886
Ensembl chr X:115,565,267...115,598,809
G
Lox
lysyl oxidase
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LOX mRNA
CTD
PMID:36139627
NCBI chr18:45,964,544...45,977,431
Ensembl chr18:45,967,343...46,041,477
G
Lratd2
LRAT domain containing 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LRATD2 mRNA
CTD
PMID:36139627
NCBI chr 7:92,376,713...92,387,045
Ensembl chr 7:92,362,194...92,388,189
G
Lrrc37a
leucine rich repeat containing 37A
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LRRC37A3 mRNA
CTD
PMID:36139627
NCBI chr10:88,395,837...88,433,519
Ensembl chr10:88,396,663...88,433,323
G
Lsr
lipolysis stimulated lipoprotein receptor
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LSR mRNA
CTD
PMID:36139627
NCBI chr 1:86,185,769...86,201,952
Ensembl chr 1:86,186,431...86,201,952
G
Ltbp1
latent transforming growth factor beta binding protein 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LTBP1 mRNA
CTD
PMID:36139627
NCBI chr 6:20,029,629...20,425,339
Ensembl chr 6:20,029,629...20,425,349
G
Ltbp2
latent transforming growth factor beta binding protein 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LTBP2 mRNA
CTD
PMID:36139627
NCBI chr 6:104,429,947...104,530,498
Ensembl chr 6:104,429,947...104,526,208
G
Lyst
lysosomal trafficking regulator
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of LYST mRNA
CTD
PMID:36139627
NCBI chr17:86,241,384...86,443,501
Ensembl chr17:86,241,384...86,443,480
G
Lzts1
leucine zipper tumor suppressor 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of LZTS1 mRNA
CTD
PMID:36139627
NCBI chr16:20,542,756...20,598,204
Ensembl chr16:20,542,809...20,598,203
G
Mad1l1
mitotic arrest deficient 1 like 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MAD1L1 mRNA
CTD
PMID:36139627
NCBI chr12:14,320,892...14,630,750
Ensembl chr12:14,320,892...14,630,703
G
Maff
MAF bZIP transcription factor F
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MAFF mRNA
CTD
PMID:36139627
NCBI chr 7:110,912,367...110,923,711
Ensembl chr 7:110,912,499...110,923,851
G
Map1a
microtubule-associated protein 1A
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MAP1A mRNA
CTD
PMID:36139627
NCBI chr 3:108,263,217...108,283,936
Ensembl chr 3:108,263,151...108,282,899
G
Map4k1
mitogen activated protein kinase kinase kinase kinase 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MAP4K1 mRNA
CTD
PMID:36139627
NCBI chr 1:84,270,951...84,292,496
Ensembl chr 1:84,271,069...84,292,493
G
Mapk1
mitogen activated protein kinase 1
multiple interactions decreases phosphorylation
ISO
KRAS protein affects the reaction [sotorasib results in decreased phosphorylation of MAPK1 protein]
CTD
PMID:31666701
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
decreases phosphorylation multiple interactions
ISO
sotorasib results in decreased phosphorylation of MAPK3 protein KRAS protein affects the reaction [sotorasib results in decreased phosphorylation of MAPK3 protein]
CTD
PMID:31666701
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Marchf4
membrane associated ring-CH-type finger 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MARCHF4 mRNA
CTD
PMID:36139627
NCBI chr 9:74,078,437...74,196,070
Ensembl chr 9:74,078,434...74,198,199
G
Mast4
microtubule associated serine/threonine kinase family member 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MAST4 mRNA
CTD
PMID:36139627
NCBI chr 2:33,893,241...34,483,682
Ensembl chr 2:33,894,436...34,483,723
G
Matn2
matrilin 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MATN2 mRNA
CTD
PMID:36139627
NCBI chr 7:65,494,996...65,644,613
Ensembl chr 7:65,494,834...65,645,113
G
Mctp1
multiple C2 and transmembrane domain containing 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MCTP1 mRNA
CTD
PMID:36139627
NCBI chr 2:6,071,408...6,761,833
Ensembl chr 2:6,065,808...6,761,833
G
Mdga1
MAM domain containing glycosylphosphatidylinositol anchor 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MDGA1 mRNA
CTD
PMID:36139627
NCBI chr20:7,900,327...7,964,309
Ensembl chr20:7,904,358...7,963,471
G
Meis1
Meis homeobox 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MEIS1 mRNA
CTD
PMID:36139627
NCBI chr14:93,155,426...93,294,373
Ensembl chr14:93,155,419...93,294,265
G
Mest
mesoderm specific transcript
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MEST mRNA
CTD
PMID:36139627
NCBI chr 4:59,354,445...59,364,919
Ensembl chr 4:59,354,447...59,366,145
G
MGC94891
hypothetical protein LOC681210
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of C6ORF118 mRNA
CTD
PMID:36139627
NCBI chr 1:51,740,328...51,764,041
Ensembl chr 1:51,740,330...51,763,989
G
Mid1
midline 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MID1 mRNA
CTD
PMID:36139627
NCBI chr X:24,116,674...24,491,205
Ensembl chr X:24,120,293...24,248,353
G
Milr1
mast cell immunoglobulin-like receptor 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MILR1 mRNA
CTD
PMID:36139627
NCBI chr10:91,684,288...91,705,284
Ensembl chr10:91,687,831...91,705,282
G
Mlph
melanophilin
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MLPH mRNA
CTD
PMID:36139627
NCBI chr 9:91,507,410...91,542,984
Ensembl chr 9:91,507,591...91,542,983
G
Mmp1
matrix metallopeptidase 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MMP1 mRNA
CTD
PMID:36139627
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
G
Mmp12
matrix metallopeptidase 12
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MMP12 mRNA
CTD
PMID:36139627
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
G
Mmp13
matrix metallopeptidase 13
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MMP13 mRNA
CTD
PMID:36139627
NCBI chr 8:4,497,960...4,508,239
Ensembl chr 8:4,497,960...4,508,239
G
Mmp14
matrix metallopeptidase 14
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MMP14 mRNA
CTD
PMID:36139627
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
G
Mmp19
matrix metallopeptidase 19
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MMP19 mRNA
CTD
PMID:36139627
NCBI chr 7:1,221,229...1,229,555
Ensembl chr 7:1,221,343...1,229,555
G
Mmp3
matrix metallopeptidase 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MMP3 mRNA
CTD
PMID:36139627
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
G
Mmp9
matrix metallopeptidase 9
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MMP9 mRNA
CTD
PMID:36139627
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Morn3
MORN repeat containing 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MORN3 mRNA
CTD
PMID:36139627
NCBI chr12:33,505,654...33,529,918
Ensembl chr12:33,514,230...33,529,931
G
Mpzl2
myelin protein zero-like 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MPZL2 mRNA
CTD
PMID:36139627
NCBI chr 8:45,348,285...45,359,298
Ensembl chr 8:45,348,285...45,359,298
G
Mrap2
melanocortin 2 receptor accessory protein 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MRAP2 mRNA
CTD
PMID:36139627
NCBI chr 8:88,088,293...88,144,636
Ensembl chr 8:88,088,272...88,143,886
G
Muc3a
mucin 3A, cell surface associated
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MUC3A mRNA
CTD
PMID:36139627
NCBI chr12:19,450,679...19,454,753
G
Muc5b
mucin 5B, oligomeric mucus/gel-forming
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MUC5B mRNA
CTD
PMID:36139627
NCBI chr 1:196,916,861...196,948,830
Ensembl chr 1:196,916,825...196,949,250
G
Mybph
myosin binding protein H
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MYBPH mRNA
CTD
PMID:36139627
NCBI chr13:45,653,156...45,660,893
Ensembl chr13:45,653,234...45,660,893
G
Myh15
myosin, heavy chain 15
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MYH15 mRNA
CTD
PMID:36139627
NCBI chr11:51,621,924...51,763,037
Ensembl chr11:51,622,413...51,762,971
G
Myo10
myosin X
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MYO10 mRNA
CTD
PMID:36139627
NCBI chr 2:76,100,989...76,305,619
Ensembl chr 2:76,100,987...76,303,030
G
Myo15a
myosin XVA
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MYO15A mRNA
CTD
PMID:36139627
NCBI chr10:45,277,619...45,335,953
Ensembl chr10:45,278,737...45,335,340
G
Myo15b
myosin XVB
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MYO15B mRNA
CTD
PMID:36139627
NCBI chr10:101,088,734...101,126,159
Ensembl chr10:101,104,209...101,125,693
G
Myo5c
myosin VC
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MYO5C mRNA
CTD
PMID:36139627
NCBI chr 8:75,989,497...76,066,485
Ensembl chr 8:75,989,528...76,066,483
G
Myo7b
myosin VIIb
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of MYO7B mRNA
CTD
PMID:36139627
NCBI chr18:23,588,307...23,669,841
Ensembl chr18:23,588,307...23,669,809
G
N4bp3
Nedd4 binding protein 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of N4BP3 mRNA
CTD
PMID:36139627
NCBI chr10:35,898,031...35,906,704
Ensembl chr10:35,899,096...35,907,001
G
Nav3
neuron navigator 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NAV3 mRNA
CTD
PMID:36139627
NCBI chr 7:45,052,206...45,840,471
Ensembl chr 7:45,054,296...45,840,698
G
Ndrg1
N-myc downstream regulated 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NDRG1 mRNA
CTD
PMID:36139627
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
G
Ndrg4
NDRG family member 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NDRG4 mRNA
CTD
PMID:36139627
NCBI chr19:9,351,408...9,387,398
Ensembl chr19:9,351,404...9,386,914
G
Ndufv2
NADH:ubiquinone oxidoreductase core subunit V2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NDUFV2 mRNA
CTD
PMID:36139627
NCBI chr 9:105,690,454...105,710,669
Ensembl chr 9:105,690,455...105,710,713
G
Nedd9
neural precursor cell expressed, developmentally down-regulated 9
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of NEDD9 mRNA
CTD
PMID:36139627
NCBI chr17:23,289,793...23,468,026
Ensembl chr17:23,282,326...23,468,019
G
Nes
nestin
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NES mRNA
CTD
PMID:36139627
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
G
Neurl3
neuralized E3 ubiquitin protein ligase 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NEURL3 mRNA
CTD
PMID:36139627
NCBI chr 9:38,494,486...38,503,352
Ensembl chr 9:38,494,489...38,502,649
G
Ngef
neuronal guanine nucleotide exchange factor
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NGEF mRNA
CTD
PMID:36139627
NCBI chr 9:88,146,956...88,244,454
Ensembl chr 9:88,146,956...88,244,914
G
Nhsl1
NHS-like 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NHSL1 mRNA
CTD
PMID:36139627
NCBI chr 1:12,956,525...13,188,580
Ensembl chr 1:12,956,021...13,187,547
G
Nhsl2
NHS-like 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NHSL2 mRNA
CTD
PMID:36139627
NCBI chr X:66,969,953...67,209,464
Ensembl chr X:66,970,151...67,200,911
G
Nim1k
NIM1 serine/threonine protein kinase
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NIM1K mRNA
CTD
PMID:36139627
NCBI chr 2:51,670,764...51,714,782
Ensembl chr 2:51,670,772...51,714,762
G
Nipal4
NIPA-like domain containing 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NIPAL4 mRNA
CTD
PMID:36139627
NCBI chr10:30,583,926...30,600,640
Ensembl chr10:30,583,926...30,600,640
G
Nkx2-1
NK2 homeobox 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NKX2-1 mRNA
CTD
PMID:36139627
NCBI chr 6:73,996,601...74,001,483
Ensembl chr 6:73,996,601...73,999,791
G
Nlgn1
neuroligin 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NLGN1 mRNA
CTD
PMID:36139627
NCBI chr 2:108,256,236...109,181,530
Ensembl chr 2:108,257,824...109,002,464
G
Nlrp1a
NLR family, pyrin domain containing 1A
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NLRP1 mRNA
CTD
PMID:36139627
NCBI chr10:55,778,560...55,833,639
Ensembl chr10:55,778,560...55,825,180
G
Nmnat2
nicotinamide nucleotide adenylyltransferase 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of NMNAT2 mRNA
CTD
PMID:36139627
NCBI chr13:65,105,950...65,277,350
Ensembl chr13:65,105,950...65,278,484
G
Nog
noggin
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NOG mRNA
CTD
PMID:36139627
NCBI chr10:74,128,712...74,130,339
Ensembl chr10:74,128,712...74,130,339
G
Notch4
notch receptor 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NOTCH4 mRNA
CTD
PMID:36139627
NCBI chr20:4,160,362...4,184,466
Ensembl chr20:4,160,445...4,184,465
G
Npas1
neuronal PAS domain protein 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NPAS1 mRNA
CTD
PMID:36139627
NCBI chr 1:77,167,375...77,187,887
Ensembl chr 1:77,167,381...77,186,762
G
Npb
neuropeptide B
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of NPB mRNA
CTD
PMID:36139627
NCBI chr10:105,883,992...105,887,689
Ensembl chr10:105,874,708...105,887,254
G
Npr3
natriuretic peptide receptor 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NPR3 mRNA
CTD
PMID:36139627
NCBI chr 2:60,865,483...60,933,432
Ensembl chr 2:60,870,594...60,932,955
G
Nptx1
neuronal pentraxin 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NPTX1 mRNA
CTD
PMID:36139627
NCBI chr10:104,811,107...104,820,358
Ensembl chr10:104,811,403...104,820,367
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NR1D1 mRNA
CTD
PMID:36139627
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NR3C2 mRNA
CTD
PMID:36139627
NCBI chr19:30,715,634...31,059,885
Ensembl chr19:30,715,648...31,059,885
G
Nrep
neuronal regeneration related protein
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NREP mRNA
CTD
PMID:36139627
NCBI chr18:25,017,069...25,046,593
Ensembl chr18:25,017,083...25,046,591
G
Nrp1
neuropilin 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of NRP1 mRNA
CTD
PMID:36139627
NCBI chr19:56,359,455...56,514,628
Ensembl chr19:56,359,455...56,513,633
G
Nrp2
neuropilin 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NRP2 mRNA
CTD
PMID:36139627
NCBI chr 9:64,122,815...64,238,007
Ensembl chr 9:64,123,132...64,237,958
G
Nt5e
5' nucleotidase, ecto
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NT5E mRNA
CTD
PMID:36139627
NCBI chr 8:89,271,046...89,314,918
Ensembl chr 8:89,270,696...89,314,881
G
Ntsr1
neurotensin receptor 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NTSR1 mRNA
CTD
PMID:36139627
NCBI chr 3:167,606,215...167,656,371
Ensembl chr 3:167,606,215...167,656,377
G
Nyap1
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of NYAP1 mRNA
CTD
PMID:36139627
NCBI chr12:18,956,192...18,967,624
Ensembl chr12:18,956,268...18,967,543
G
Oas1a
2'-5' oligoadenylate synthetase 1A
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of OAS1 mRNA
CTD
PMID:36139627
NCBI chr12:35,669,798...35,680,505
Ensembl chr12:35,669,801...35,680,517
G
Oas3
2'-5'-oligoadenylate synthetase 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of OAS3 mRNA
CTD
PMID:36139627
NCBI chr12:35,779,028...35,802,781
Ensembl chr12:35,779,022...35,802,781
G
Oasl
2'-5'-oligoadenylate synthetase-like
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of OASL mRNA
CTD
PMID:36139627
NCBI chr12:41,682,900...41,695,641
Ensembl chr12:41,682,900...41,695,641
G
Obscn
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of OBSCN mRNA
CTD
PMID:36139627
NCBI chr10:43,774,113...43,919,718
Ensembl chr10:43,789,293...43,919,723
G
Onecut3
one cut homeobox 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ONECUT3 mRNA
CTD
PMID:36139627
NCBI chr 7:9,199,997...9,219,303
Ensembl chr 7:9,200,035...9,219,158 Ensembl chr 7:9,200,035...9,219,158
G
Osgin1
oxidative stress induced growth inhibitor 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of OSGIN1 mRNA
CTD
PMID:36139627
NCBI chr19:47,471,750...47,500,517
Ensembl chr19:47,492,171...47,500,516
G
P2rx6
purinergic receptor P2X 6
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of P2RX6 mRNA
CTD
PMID:36139627
NCBI chr11:83,439,922...83,450,449
Ensembl chr11:83,439,924...83,450,481
G
P3h2
prolyl 3-hydroxylase 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of P3H2 mRNA
CTD
PMID:36139627
NCBI chr11:74,634,267...74,775,422
Ensembl chr11:74,634,267...74,775,421
G
Pag1
phosphoprotein membrane anchor with glycosphingolipid microdomains 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PAG1 mRNA
CTD
PMID:36139627
NCBI chr 2:91,935,378...92,076,937
Ensembl chr 2:92,057,216...92,069,849
G
Paqr5
progestin and adipoQ receptor family member 5
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PAQR5 mRNA
CTD
PMID:36139627
NCBI chr 8:62,431,867...62,513,688
Ensembl chr 8:62,431,867...62,513,688
G
Paqr9
progestin and adipoQ receptor family member 9
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PAQR9 mRNA
CTD
PMID:36139627
NCBI chr 8:96,114,249...96,116,546
G
Pbld1
phenazine biosynthesis-like protein domain containing 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PBLD mRNA
CTD
PMID:36139627
NCBI chr20:25,551,274...25,566,543
Ensembl chr20:25,551,275...25,565,614
G
Pcdhb19
protocadherin beta 19
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PCDHB12 mRNA
CTD
PMID:36139627
NCBI chr18:29,204,838...29,207,646
G
Pde2a
phosphodiesterase 2A
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PDE2A mRNA
CTD
PMID:36139627
NCBI chr 1:155,823,590...155,915,434
Ensembl chr 1:155,813,180...155,915,434
G
Pdp2
pyruvate dehydrogenase phosphatase catalytic subunit 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PDP2 mRNA
CTD
PMID:36139627
NCBI chr19:386,408...394,068
Ensembl chr19:386,406...394,074
G
Per1
period circadian regulator 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PER1 mRNA
CTD
PMID:36139627
NCBI chr10:53,800,126...53,814,963
Ensembl chr10:53,805,535...53,814,431
G
Pfkfb4
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PFKFB4 mRNA
CTD
PMID:36139627
NCBI chr 8:109,643,558...109,687,006
Ensembl chr 8:109,643,937...109,685,634
G
Pfn4
profilin family, member 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PFN4 mRNA
CTD
PMID:36139627
NCBI chr 6:27,786,619...27,796,710
Ensembl chr 6:27,786,619...27,796,710
G
Pgbd5
piggyBac transposable element derived 5
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PGBD5 mRNA
CTD
PMID:36139627
NCBI chr19:52,336,751...52,401,906
Ensembl chr19:52,336,751...52,402,397
G
Phlda2
pleckstrin homology-like domain, family A, member 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PHLDA2 mRNA
CTD
PMID:36139627
NCBI chr 1:198,696,897...198,699,292
Ensembl chr 1:198,696,897...198,697,836
G
Phospho1
phosphoethanolamine/phosphocholine phosphatase 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PHOSPHO1 mRNA
CTD
PMID:36139627
NCBI chr10:80,762,062...80,769,596
Ensembl chr10:80,760,792...80,770,342
G
Phtf1
putative homeodomain transcription factor 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PHTF1 mRNA
CTD
PMID:36139627
NCBI chr 2:191,470,849...191,537,399
Ensembl chr 2:191,473,130...191,512,078
G
Phyhip
phytanoyl-CoA 2-hydroxylase interacting protein
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PHYHIP mRNA
CTD
PMID:36139627
NCBI chr15:45,533,974...45,545,223
Ensembl chr15:45,533,974...45,545,221
G
Piezo2
piezo-type mechanosensitive ion channel component 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PIEZO2 mRNA
CTD
PMID:36139627
NCBI chr18:56,468,449...56,844,984
Ensembl chr18:56,469,680...56,844,216
G
Pik3ip1
phosphoinositide-3-kinase interacting protein 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PIK3IP1 mRNA
CTD
PMID:36139627
NCBI chr14:78,204,668...78,216,616
Ensembl chr14:78,204,053...78,216,608
G
Pik3r3
phosphoinositide-3-kinase regulatory subunit 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PIK3R3 mRNA
CTD
PMID:36139627
NCBI chr 5:129,700,925...129,772,591
Ensembl chr 5:129,701,229...129,772,583
G
Piwil2
piwi-like RNA-mediated gene silencing 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PIWIL2 mRNA
CTD
PMID:36139627
NCBI chr15:45,431,402...45,498,034
Ensembl chr15:45,431,703...45,497,702
G
Pkd1l2
polycystin 1 like 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PKD1L2 mRNA
CTD
PMID:36139627
NCBI chr19:45,049,713...45,136,503
Ensembl chr19:45,049,719...45,135,532
G
Plac1
placenta enriched 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PLAC1 mRNA
CTD
PMID:36139627
NCBI chr X:132,821,347...132,955,143
Ensembl chr X:132,821,347...132,985,668
G
Plag1
PLAG1 zinc finger
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PLAG1 mRNA
CTD
PMID:36139627
NCBI chr 5:16,902,057...16,956,727
Ensembl chr 5:16,905,394...16,913,647
G
Plat
plasminogen activator, tissue type
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PLAT mRNA
CTD
PMID:36139627
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Plaur
plasminogen activator, urokinase receptor
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PLAUR mRNA
CTD
PMID:36139627
NCBI chr 1:80,053,440...80,068,384
Ensembl chr 1:80,050,324...80,068,595
G
Plcxd3
phosphatidylinositol-specific phospholipase C, X domain containing 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PLCXD3 mRNA
CTD
PMID:36139627
NCBI chr 2:53,567,022...53,746,384
Ensembl chr 2:53,567,022...53,746,384
G
Pld1
phospholipase D1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PLD1 mRNA
CTD
PMID:36139627
NCBI chr 2:110,849,205...111,047,304
Ensembl chr 2:110,893,608...111,047,692
G
Plek2
pleckstrin 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PLEK2 mRNA
CTD
PMID:36139627
NCBI chr 6:97,700,123...97,719,417
Ensembl chr 6:97,701,106...97,719,326
G
Plin1
perilipin 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PLIN1 mRNA
CTD
PMID:36139627
NCBI chr 1:133,664,294...133,676,854
Ensembl chr 1:133,664,892...133,676,828
G
Plin4
perilipin 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PLIN4 mRNA
CTD
PMID:36139627
NCBI chr 9:929,168...938,062
Ensembl chr 9:929,176...938,056
G
Plxna2
plexin A2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PLXNA2 mRNA
CTD
PMID:36139627
NCBI chr13:106,163,103...106,358,979
Ensembl chr13:106,163,103...106,358,979
G
Podxl
podocalyxin-like
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PODXL mRNA
CTD
PMID:36139627
NCBI chr 4:60,135,124...60,181,829
Ensembl chr 4:60,135,109...60,181,899
G
Pou2f2
POU class 2 homeobox 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of POU2F2 mRNA
CTD
PMID:36139627
NCBI chr 1:80,682,330...80,769,756
Ensembl chr 1:80,685,741...80,724,261
G
Pou2f3
POU class 2 homeobox 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of POU2F3 mRNA
CTD
PMID:36139627
NCBI chr 8:43,495,408...43,577,795
Ensembl chr 8:43,495,527...43,577,795
G
Pou6f1
POU class 6 homeobox 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of POU6F1 mRNA
CTD
PMID:36139627
NCBI chr 7:131,677,719...131,700,869
Ensembl chr 7:131,680,141...131,686,843 Ensembl chr 7:131,680,141...131,686,843
G
Ppfia3
PTPRF interacting protein alpha 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PPFIA3 mRNA
CTD
PMID:36139627
NCBI chr 1:95,817,110...95,845,950
Ensembl chr 1:95,817,110...95,845,798
G
Ppm1n
protein phosphatase, Mg2+/Mn2+ dependent 1N
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PPM1N mRNA
CTD
PMID:36139627
NCBI chr 1:78,929,350...78,934,435
Ensembl chr 1:78,929,351...78,932,685
G
Ppp1r16b
protein phosphatase 1, regulatory subunit 16B
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PPP1R16B mRNA
CTD
PMID:36139627
NCBI chr 3:147,323,652...147,419,658
Ensembl chr 3:147,324,126...147,418,937
G
Prag1
PEAK1 related kinase activating pseudokinase 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PRAG1 mRNA
CTD
PMID:36139627
NCBI chr16:56,087,885...56,141,153
Ensembl chr16:56,087,885...56,141,153
G
Prex1
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PREX1 mRNA
CTD
PMID:36139627
NCBI chr 3:155,306,950...155,456,688
Ensembl chr 3:155,306,950...155,456,688
G
Prickle1
prickle planar cell polarity protein 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PRICKLE1 mRNA
CTD
PMID:36139627
NCBI chr 7:124,639,142...124,735,027
Ensembl chr 7:124,639,142...124,658,113
G
Prkg2
protein kinase cGMP-dependent 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PRKG2 mRNA
CTD
PMID:36139627
NCBI chr14:10,559,882...10,668,479
Ensembl chr14:10,559,882...10,666,888
G
Prnd
prion like protein doppel
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PRND mRNA
CTD
PMID:36139627
NCBI chr 3:119,213,462...119,218,742
Ensembl chr 3:119,213,429...119,218,745
G
Prodh
proline dehydrogenase
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PRODH mRNA
CTD
PMID:36139627
NCBI chr11:82,910,043...82,927,305
Ensembl chr11:82,910,137...82,927,305
G
Prodh2
proline dehydrogenase 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PRODH2 mRNA
CTD
PMID:36139627
NCBI chr 1:85,753,558...85,767,165
Ensembl chr 1:85,753,644...85,767,162
G
Prr5l
proline rich 5 like
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PRR5L mRNA
CTD
PMID:36139627
NCBI chr 3:88,001,951...88,173,532
Ensembl chr 3:88,003,617...88,082,763
G
Prss22
serine protease 22
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PRSS22 mRNA
CTD
PMID:36139627
NCBI chr10:13,029,153...13,033,863
Ensembl chr10:13,029,153...13,033,863
G
Prss53
serine protease 53
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PRSS53 mRNA
CTD
PMID:36139627
NCBI chr 1:182,494,944...182,501,607
Ensembl chr 1:182,494,955...182,500,115
G
Prtn3
proteinase 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PRTN3 mRNA
CTD
PMID:36139627
NCBI chr 7:9,822,123...9,831,300
Ensembl chr 7:9,822,122...9,831,944
G
Psd3
pleckstrin and Sec7 domain containing 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PSD3 mRNA
CTD
PMID:36139627
NCBI chr16:21,465,643...22,035,846
Ensembl chr16:21,465,639...22,034,547
G
Psmb10
proteasome 20S subunit beta 10
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PSMB10 mRNA
CTD
PMID:36139627
NCBI chr19:33,830,958...33,833,442
Ensembl chr19:33,827,229...33,833,626
G
Psmb9
proteasome 20S subunit beta 9
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PSMB9 mRNA
CTD
PMID:36139627
NCBI chr20:4,667,044...4,672,512
Ensembl chr20:4,666,046...4,672,512
G
Ptgir
prostaglandin I2 receptor
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PTGIR mRNA
CTD
PMID:36139627
NCBI chr 1:77,579,596...77,581,979
Ensembl chr 1:77,579,596...77,581,979
G
Ptk6
protein tyrosine kinase 6
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PTK6 mRNA
CTD
PMID:36139627
NCBI chr 3:168,307,073...168,315,664
Ensembl chr 3:168,307,073...168,315,664
G
Pxmp2
peroxisomal membrane protein 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PXMP2 mRNA
CTD
PMID:36139627
NCBI chr12:46,394,051...46,404,561
Ensembl chr12:46,394,193...46,404,557
G
Pygb
glycogen phosphorylase B
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of PYGB mRNA
CTD
PMID:36139627
NCBI chr 3:139,611,724...139,658,521
Ensembl chr 3:139,611,749...139,663,553
G
Rab11fip4
RAB11 family interacting protein 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RAB11FIP4 mRNA
CTD
PMID:36139627
NCBI chr10:64,550,109...64,658,123
Ensembl chr10:64,550,177...64,654,759
G
Rab38
RAB38, member RAS oncogene family
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RAB38 mRNA
CTD
PMID:36139627
NCBI chr 1:142,182,566...142,262,923
Ensembl chr 1:142,182,556...142,262,924
G
Rab39a
RAB39A, member RAS oncogene family
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RAB39A mRNA
CTD
PMID:36139627
NCBI chr 8:54,088,246...54,105,867
Ensembl chr 8:54,088,129...54,106,483
G
Rab7b
Rab7b, member RAS oncogene family
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RAB7B mRNA
CTD
PMID:36139627
NCBI chr13:43,121,168...43,147,581
Ensembl chr13:43,121,226...43,147,581
G
Rac2
Rac family small GTPase 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RAC2 mRNA
CTD
PMID:36139627
NCBI chr 7:110,101,344...110,128,718
Ensembl chr 7:110,116,260...110,128,720
G
Rapgef5
Rap guanine nucleotide exchange factor 5
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RAPGEF5 mRNA
CTD
PMID:36139627
NCBI chr 6:138,445,184...138,679,943
Ensembl chr 6:138,437,991...138,679,936
G
Rasa4
RAS p21 protein activator 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RASA4B mRNA
CTD
PMID:36139627
NCBI chr12:20,552,805...20,580,177
Ensembl chr12:20,552,806...20,580,147
G
Rasl11a
RAS-like family 11 member A
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of RASL11A mRNA
CTD
PMID:36139627
NCBI chr12:8,258,148...8,260,909
Ensembl chr12:8,258,159...8,262,576
G
Rassf9
Ras association domain family member 9
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RASSF9 mRNA
CTD
PMID:36139627
NCBI chr 7:37,599,720...37,631,553
Ensembl chr 7:37,599,720...37,635,245
G
Reep1
receptor accessory protein 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of REEP1 mRNA
CTD
PMID:36139627
NCBI chr 4:103,746,004...103,862,347
Ensembl chr 4:103,745,633...103,862,338
G
Rem2
RRAD and GEM like GTPase 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of REM2 mRNA
CTD
PMID:36139627
NCBI chr15:27,933,950...27,938,429
Ensembl chr15:27,933,950...27,938,429
G
Rgmb
repulsive guidance molecule BMP co-receptor b
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RGMB mRNA
CTD
PMID:36139627
NCBI chr 1:56,766,598...56,792,396
Ensembl chr 1:56,767,850...56,792,425
G
Ribc2
RIB43A domain with coiled-coils 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of RIBC2 mRNA
CTD
PMID:36139627
NCBI chr 7:116,242,863...116,257,868
Ensembl chr 7:116,242,863...116,257,863
G
Rimkla
ribosomal modification protein rimK-like family member A
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RIMKLA mRNA
CTD
PMID:36139627
NCBI chr 5:133,072,179...133,098,840
Ensembl chr 5:133,073,960...133,098,792
G
Rnf182
ring finger protein 182
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RNF182 mRNA
CTD
PMID:36139627
NCBI chr17:21,026,110...21,081,760
Ensembl chr17:21,030,214...21,094,911
G
Rnf223
ring finger protein 223
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RNF223 mRNA
CTD
PMID:36139627
NCBI chr 5:166,723,346...166,726,236
Ensembl chr 5:166,724,984...166,725,751
G
Robo4
roundabout guidance receptor 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ROBO4 mRNA
CTD
PMID:36139627
NCBI chr 8:37,119,953...37,133,887
Ensembl chr 8:37,119,988...37,132,519
G
Ror2
receptor tyrosine kinase-like orphan receptor 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ROR2 mRNA
CTD
PMID:36139627
NCBI chr17:11,972,830...12,148,152
Ensembl chr17:11,972,830...12,148,152
G
Rora
RAR-related orphan receptor A
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RORA mRNA
CTD
PMID:36139627
NCBI chr 8:69,301,635...70,034,741
Ensembl chr 8:69,301,733...70,025,931
G
Rps6
ribosomal protein S6
decreases phosphorylation
ISO
sotorasib results in decreased phosphorylation of RPS6 protein
CTD
PMID:31666701
NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:101,371,136...101,374,602 Ensembl chr 5:101,371,136...101,374,602
G
Rragd
Ras-related GTP binding D
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RRAGD mRNA
CTD
PMID:36139627
NCBI chr 5:47,373,902...47,409,369
Ensembl chr 5:47,373,463...47,409,356
G
Rspo1
R-spondin 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of RSPO1 mRNA
CTD
PMID:36139627
NCBI chr 5:137,251,629...137,273,273
Ensembl chr 5:137,251,659...137,272,933
G
RT1-Ha
RT1 class II, locus Ha
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of HLA-DPA1 mRNA
CTD
PMID:36139627
NCBI chr20:4,760,631...4,770,662
Ensembl chr20:4,760,118...4,770,244
G
Rtn2
reticulon 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RTN2 mRNA
CTD
PMID:36139627
NCBI chr 1:78,935,056...78,948,069
Ensembl chr 1:78,935,104...78,948,069
G
Rtp4
receptor (chemosensory) transporter protein 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of RTP4 mRNA
CTD
PMID:36139627
NCBI chr11:77,237,341...77,249,194
Ensembl chr11:77,238,216...77,335,437
G
Runx2
RUNX family transcription factor 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RUNX2 mRNA
CTD
PMID:36139627
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
G
Rxfp4
relaxin family peptide/INSL5 receptor 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RXFP4 mRNA
CTD
PMID:36139627
NCBI chr 2:174,123,510...174,124,664
G
Ryr1
ryanodine receptor 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of RYR1 mRNA
CTD
PMID:36139627
NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:84,292,578...84,423,812
G
S100a2
S100 calcium binding protein A2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of S100A2 mRNA
CTD
PMID:36139627
NCBI chr 2:176,077,081...176,078,325
G
Sall4
spalt-like transcription factor 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SALL4 mRNA
CTD
PMID:36139627
NCBI chr 3:157,474,067...157,491,055
Ensembl chr 3:157,474,642...157,490,822
G
Samd15
sterile alpha motif domain containing 15
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SAMD15 mRNA
CTD
PMID:36139627
NCBI chr 6:106,841,405...106,856,197
Ensembl chr 6:106,840,781...106,860,423
G
Samd9l
sterile alpha motif domain containing 9 like
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SAMD9L mRNA
CTD
PMID:36139627
NCBI chr 4:31,362,054...31,376,412
Ensembl chr 4:31,361,669...31,376,415
G
Saxo5
stabilizer of axonemal microtubules 5
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SAXO5 mRNA
CTD
PMID:36139627
NCBI chr12:1,520,983...1,538,127
Ensembl chr12:1,521,014...1,538,118
G
Scarf1
scavenger receptor class F, member 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SCARF1 mRNA
CTD
PMID:36139627
NCBI chr10:60,359,213...60,371,516
Ensembl chr10:60,359,197...60,371,516
G
Scnn1b
sodium channel epithelial 1 subunit beta
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SCNN1B mRNA
CTD
PMID:36139627
NCBI chr 1:176,430,063...176,484,451
Ensembl chr 1:176,430,103...176,484,451
G
Sdcbp2
syndecan binding protein 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SDCBP2 mRNA
CTD
PMID:36139627
NCBI chr 3:140,060,746...140,098,063
Ensembl chr 3:140,070,540...140,098,057
G
Sec14l2
SEC14-like lipid binding 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SEC14L2 mRNA
CTD
PMID:36139627
NCBI chr14:78,973,805...78,998,480
Ensembl chr14:78,973,808...78,993,788
G
Sema3c
semaphorin 3C
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SEMA3C mRNA
CTD
PMID:36139627
NCBI chr 4:17,583,212...17,747,234
Ensembl chr 4:17,583,212...17,746,534
G
Sema7a
semaphorin 7A (John Milton Hagen blood group)
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SEMA7A mRNA
CTD
PMID:36139627
NCBI chr 8:58,348,448...58,370,536
Ensembl chr 8:58,348,448...58,370,536
G
Serpina3n
serpin family A member 3N
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SERPINA3 mRNA
CTD
PMID:36139627
NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:123,323,629...123,332,433
G
Serpina5
serpin family A member 5
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SERPINA5 mRNA
CTD
PMID:36139627
NCBI chr 6:123,009,224...123,028,412
Ensembl chr 6:123,023,306...123,028,407
G
Serpinb8
serpin family B member 8
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SERPINB8 mRNA
CTD
PMID:36139627
NCBI chr13:23,626,936...23,650,277
Ensembl chr13:23,626,945...23,650,835
G
Serpine1
serpin family E member 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SERPINE1 mRNA
CTD
PMID:36139627
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
G
Serpine2
serpin family E member 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SERPINE2 mRNA
CTD
PMID:36139627
NCBI chr 9:81,124,746...81,188,866
Ensembl chr 9:81,124,804...81,188,826
G
Serpini1
serpin family I member 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SERPINI1 mRNA
CTD
PMID:36139627
NCBI chr 2:160,346,403...160,433,135
Ensembl chr 2:160,346,758...160,433,135
G
Sfn
stratifin
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SFN mRNA
CTD
PMID:36139627
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
G
Sfxn2
sideroflexin 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SFXN2 mRNA
CTD
PMID:36139627
NCBI chr 1:245,447,014...245,459,312
Ensembl chr 1:245,447,015...245,468,411 Ensembl chr 1:245,447,015...245,468,411
G
Sfxn3
sideroflexin 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SFXN3 mRNA
CTD
PMID:36139627
NCBI chr 1:243,907,958...243,917,065
Ensembl chr 1:243,907,751...243,917,073
G
Sh2d5
SH2 domain containing 5
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SH2D5 mRNA
CTD
PMID:36139627
NCBI chr 5:150,469,738...150,480,615
Ensembl chr 5:150,467,728...150,479,955
G
Sh3d21
SH3 domain containing 21
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SH3D21 mRNA
CTD
PMID:36139627
NCBI chr 5:138,429,180...138,444,540
Ensembl chr 5:138,429,180...138,444,407
G
Sh3tc2
SH3 domain and tetratricopeptide repeats 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SH3TC2 mRNA
CTD
PMID:36139627
NCBI chr18:55,416,383...55,477,419
Ensembl chr18:55,416,413...55,483,083
G
Shf
Src homology 2 domain containing F
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SHF mRNA
CTD
PMID:36139627
NCBI chr 3:109,296,517...109,316,315
Ensembl chr 3:109,296,784...109,316,328
G
Siglec15
sialic acid binding Ig-like lectin 15
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SIGLEC15 mRNA
CTD
PMID:36139627
NCBI chr18:71,506,416...71,521,894
Ensembl chr18:71,505,399...71,521,881
G
Slc10a5
solute carrier family 10, member 5
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SLC10A5 mRNA
CTD
PMID:36139627
NCBI chr 2:91,457,540...91,458,844
Ensembl chr 2:91,444,454...91,489,651
G
Slc17a7
solute carrier family 17 member 7
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SLC17A7 mRNA
CTD
PMID:36139627
NCBI chr 1:95,649,709...95,661,591
Ensembl chr 1:95,649,745...95,661,588
G
Slc2a3
solute carrier family 2 member 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SLC2A3 mRNA
CTD
PMID:36139627
NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:155,960,946...156,025,472
G
Slc47a2
solute carrier family 47 member 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SLC47A2 mRNA
CTD
PMID:36139627
NCBI chr10:45,990,806...46,033,937
Ensembl chr10:45,991,095...46,033,904
G
Slc4a11
solute carrier family 4 member 11
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SLC4A11 mRNA
CTD
PMID:36139627
NCBI chr 3:117,900,223...117,912,787
Ensembl chr 3:117,900,223...117,912,674
G
Slc4a7
solute carrier family 4 member 7
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SLC4A7 mRNA
CTD
PMID:36139627
NCBI chr15:10,585,307...10,664,780
Ensembl chr15:10,588,979...10,664,781
G
Slc5a1
solute carrier family 5 member 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SLC5A1 mRNA
CTD
PMID:36139627
NCBI chr14:77,553,990...77,618,589
Ensembl chr14:77,553,843...77,618,547
G
Slc6a9
solute carrier family 6 member 9
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SLC6A9 mRNA
CTD
PMID:36139627
NCBI chr 5:131,374,562...131,408,733
Ensembl chr 5:131,374,542...131,408,728
G
Slc9a3
solute carrier family 9 member A3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SLC9A3 mRNA
CTD
PMID:36139627
NCBI chr 1:29,124,633...29,167,912
Ensembl chr 1:29,124,674...29,167,417
G
Slitrk3
SLIT and NTRK-like family, member 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SLITRK3 mRNA
CTD
PMID:36139627
NCBI chr 2:157,680,067...157,697,404
Ensembl chr 2:157,687,535...157,696,709
G
Smim5
small integral membrane protein 5
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SMIM5 mRNA
CTD
PMID:36139627
NCBI chr10:101,134,033...101,139,814
Ensembl chr10:101,134,033...101,139,813
G
Smoc2
SPARC related modular calcium binding 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SMOC2 mRNA
CTD
PMID:36139627
NCBI chr 1:55,262,472...55,391,804
Ensembl chr 1:55,262,530...55,391,693
G
Smpd3
sphingomyelin phosphodiesterase 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SMPD3 mRNA
CTD
PMID:36139627
NCBI chr19:34,162,337...34,245,786
Ensembl chr19:34,162,341...34,245,749
G
Snai2
snail family transcriptional repressor 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SNAI2 mRNA
CTD
PMID:36139627
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
G
Snai3
snail family transcriptional repressor 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SNAI3 mRNA
CTD
PMID:36139627
NCBI chr19:50,516,771...50,529,295
Ensembl chr19:50,516,771...50,523,486
G
Socs2
suppressor of cytokine signaling 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SOCS2 mRNA
CTD
PMID:36139627
NCBI chr 7:30,006,360...30,045,161
Ensembl chr 7:30,008,578...30,043,548
G
Spata18
spermatogenesis associated 18
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SPATA18 mRNA
CTD
PMID:36139627
NCBI chr14:34,531,931...34,558,671
Ensembl chr14:34,531,061...34,558,687
G
Spats2l
spermatogenesis associated, serine-rich 2-like
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SPATS2L mRNA
CTD
PMID:36139627
NCBI chr 9:59,319,949...59,493,864
Ensembl chr 9:59,320,276...59,493,967
G
Spns3
SPNS lysolipid transporter 3, sphingosine-1-phosphate
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SPNS3 mRNA
CTD
PMID:36139627
NCBI chr10:57,114,247...57,169,056
Ensembl chr10:57,114,266...57,168,951
G
Spocd1
SPOC domain containing 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SPOCD1 mRNA
CTD
PMID:36139627
NCBI chr 5:142,288,822...142,297,113
G
Spon1
spondin 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SPON1 mRNA
CTD
PMID:36139627
NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:167,928,972...168,228,226
G
Spsb1
splA/ryanodine receptor domain and SOCS box containing 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SPSB1 mRNA
CTD
PMID:36139627
NCBI chr 5:160,358,292...160,418,541
Ensembl chr 5:160,358,308...160,418,468
G
Sptb
spectrin, beta, erythrocytic
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SPTB mRNA
CTD
PMID:36139627
NCBI chr 6:95,310,342...95,437,221
Ensembl chr 6:95,310,326...95,437,118
G
Sptbn4
spectrin, beta, non-erythrocytic 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SPTBN4 mRNA
CTD
PMID:36139627
NCBI chr 1:82,650,750...82,738,345
Ensembl chr 1:82,650,751...82,737,228
G
Srxn1
sulfiredoxin 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SRXN1 mRNA
CTD
PMID:36139627
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
G
St3gal1
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ST3GAL1 mRNA
CTD
PMID:36139627
NCBI chr 7:98,845,270...98,913,409
Ensembl chr 7:98,845,270...98,913,236
G
Stambpl1
STAM binding protein-like 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of STAMBPL1 mRNA
CTD
PMID:36139627
NCBI chr 1:231,699,620...231,745,034
Ensembl chr 1:231,699,995...231,745,032
G
Stc1
stanniocalcin 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of STC1 mRNA
CTD
PMID:36139627
NCBI chr15:44,299,591...44,311,695
Ensembl chr15:44,299,621...44,310,264
G
Stn1
STN1 subunit of CST complex
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of STN1 mRNA
CTD
PMID:36139627
NCBI chr 1:246,391,311...246,429,844
Ensembl chr 1:246,395,613...246,429,531
G
Stom
stomatin
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of STOM mRNA
CTD
PMID:36139627
NCBI chr 3:18,645,058...18,667,343
Ensembl chr 3:18,644,378...18,667,354
G
Sulf2
sulfatase 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SULF2 mRNA
CTD
PMID:36139627
NCBI chr 3:154,822,079...154,904,566
Ensembl chr 3:154,822,085...154,904,415
G
Sult2b1
sulfotransferase family 2B member 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SULT2B1 mRNA
CTD
PMID:36139627
NCBI chr 1:96,200,155...96,261,295
Ensembl chr 1:96,200,156...96,261,295
G
Sycp2
synaptonemal complex protein 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SYCP2 mRNA
CTD
PMID:36139627
NCBI chr 3:165,431,715...165,502,134
Ensembl chr 3:165,436,331...165,498,789
G
Sync
syncoilin, intermediate filament protein
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SYNC mRNA
CTD
PMID:36139627
NCBI chr 5:141,631,837...141,656,184
Ensembl chr 5:141,632,367...141,688,659
G
Syne3
spectrin repeat containing, nuclear envelope family member 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SYNE3 mRNA
CTD
PMID:36139627
NCBI chr 6:123,872,895...123,964,773
Ensembl chr 6:123,873,174...123,953,409
G
Syt12
synaptotagmin 12
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SYT12 mRNA
CTD
PMID:36139627
NCBI chr 1:201,729,307...201,760,192
Ensembl chr 1:201,730,371...201,759,609
G
Syt5
synaptotagmin 5
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SYT5 mRNA
CTD
PMID:36139627
NCBI chr 1:69,277,351...69,285,071
Ensembl chr 1:69,277,351...69,285,067
G
Sytl2
synaptotagmin-like 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SYTL2 mRNA
CTD
PMID:36139627
NCBI chr 1:144,272,870...144,379,310
Ensembl chr 1:144,273,360...144,379,222
G
Tac3
tachykinin precursor 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TAC3 mRNA
CTD
PMID:36139627
NCBI chr 7:63,562,552...63,569,170
Ensembl chr 7:63,562,552...63,569,170
G
Tafa2
TAFA chemokine like family member 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TAFA2 mRNA
CTD
PMID:36139627
NCBI chr 7:58,942,598...59,418,640
Ensembl chr 7:58,942,610...59,417,299
G
Tapbpl
TAP binding protein-like
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TAPBPL mRNA
CTD
PMID:36139627
NCBI chr 4:158,021,454...158,028,905
G
Tbx4
T-box transcription factor 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TBX4 mRNA
CTD
PMID:36139627
NCBI chr10:70,730,686...70,760,829
Ensembl chr10:70,731,163...70,760,825
G
Tcaf2
TRPM8 channel-associated factor 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TCAF2 mRNA
CTD
PMID:36139627
G
Tchh
trichohyalin
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TCHH mRNA
CTD
PMID:36139627
NCBI chr 2:179,103,660...179,112,014
Ensembl chr 2:179,109,609...179,110,985 Ensembl chr 2:179,109,609...179,110,985
G
Tex9
testis expressed 9
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TEX9 mRNA
CTD
PMID:36139627
NCBI chr 8:73,168,519...73,213,935
Ensembl chr 8:73,177,810...73,214,261
G
Tfpi2
tissue factor pathway inhibitor 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TFPI2 mRNA
CTD
PMID:36139627
NCBI chr 4:31,981,786...31,986,707
Ensembl chr 4:31,982,178...31,986,600
G
Tfr2
transferrin receptor 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TFR2 mRNA
CTD
PMID:36139627
NCBI chr12:19,107,673...19,124,622
Ensembl chr12:19,107,673...19,124,591
G
Tjp3
tight junction protein 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TJP3 mRNA
CTD
PMID:36139627
NCBI chr 7:8,427,650...8,446,279
Ensembl chr 7:8,432,811...8,446,279
G
Tlcd1
TLC domain containing 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TLCD1 mRNA
CTD
PMID:36139627
NCBI chr10:63,074,469...63,076,502
Ensembl chr10:63,074,469...63,076,501
G
Tle6
TLE family member 6, subcortical maternal complex member
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TLE6 mRNA
CTD
PMID:36139627
NCBI chr 7:8,107,050...8,118,639
Ensembl chr 7:8,107,207...8,118,639
G
Tlr1
toll-like receptor 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TLR1 mRNA
CTD
PMID:36139627
NCBI chr14:43,384,127...43,396,765
Ensembl chr14:43,384,932...43,397,125
G
Tlr3
toll-like receptor 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TLR3 mRNA
CTD
PMID:36139627
NCBI chr16:46,821,980...46,837,900
Ensembl chr16:46,822,039...46,836,545
G
Tlr6
toll-like receptor 6
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TLR6 mRNA
CTD
PMID:36139627
NCBI chr14:43,362,164...43,374,500
Ensembl chr14:43,362,164...43,375,685
G
Tm4sf19
transmembrane 4 L six family member 19
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TM4SF19 mRNA
CTD
PMID:36139627
NCBI chr11:68,372,945...68,386,192
Ensembl chr11:68,371,647...68,384,591
G
Tmc8
transmembrane channel-like 8
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TMC8 mRNA
CTD
PMID:36139627
NCBI chr10:103,000,038...103,010,601
Ensembl chr10:102,998,402...103,010,590
G
Tmem117
transmembrane protein 117
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TMEM117 mRNA
CTD
PMID:36139627
NCBI chr 7:125,757,591...126,219,692
Ensembl chr 7:125,757,591...126,219,690
G
Tmem144
transmembrane protein 144
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TMEM144 mRNA
CTD
PMID:36139627
NCBI chr 2:164,960,649...164,993,562
Ensembl chr 2:164,961,247...164,992,368
G
Tmem156
transmembrane protein 156
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TMEM156 mRNA
CTD
PMID:36139627
NCBI chr14:43,221,464...43,252,453
Ensembl chr14:43,223,381...43,252,449
G
Tmem158
transmembrane protein 158
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TMEM158 mRNA
CTD
PMID:36139627
NCBI chr 8:122,913,675...122,914,673
Ensembl chr 8:122,913,675...122,914,673
G
Tmem236
transmembrane protein 236
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TMEM236 mRNA
CTD
PMID:36139627
NCBI chr17:77,180,919...77,241,258
Ensembl chr17:77,188,163...77,238,671
G
Tmem25
transmembrane protein 25
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TMEM25 mRNA
CTD
PMID:36139627
NCBI chr 8:45,107,116...45,112,657
Ensembl chr 8:45,107,121...45,116,389
G
Tmem255b
transmembrane protein 255B
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TMEM255B mRNA
CTD
PMID:36139627
NCBI chr16:76,079,840...76,108,179
Ensembl chr16:76,079,845...76,106,795
G
Tmem269
transmembrane protein 269
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TMEM269 mRNA
CTD
PMID:36139627
NCBI chr 5:132,817,324...132,836,360
Ensembl chr 5:132,817,324...132,829,977
G
Tmem270
transmembrane protein 270
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TMEM270 mRNA
CTD
PMID:36139627
NCBI chr12:21,793,631...21,798,723
Ensembl chr12:21,794,130...21,798,731
G
Tmem45a
transmembrane protein 45A
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TMEM45A mRNA
CTD
PMID:36139627
NCBI chr11:43,713,309...43,799,526
Ensembl chr11:43,713,782...43,799,526
G
Tmem92
transmembrane protein 92
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TMEM92 mRNA
CTD
PMID:36139627
NCBI chr10:79,749,242...79,760,807
G
Tnfsf15
TNF superfamily member 15
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TNFSF15 mRNA
CTD
PMID:36139627
NCBI chr 5:77,134,885...77,156,171
Ensembl chr 5:77,139,878...77,156,228
G
Tnxb
tenascin XB
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TNXB mRNA
CTD
PMID:36139627
G
Tp53i3
tumor protein p53 inducible protein 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TP53I3 mRNA
CTD
PMID:36139627
NCBI chr 6:27,818,327...27,825,753
G
Tph1
tryptophan hydroxylase 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TPH1 mRNA
CTD
PMID:36139627
NCBI chr 1:97,157,375...97,178,415
Ensembl chr 1:97,157,409...97,178,344
G
Trank1
tetratricopeptide repeat and ankyrin repeat containing 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TRANK1 mRNA
CTD
PMID:36139627
NCBI chr 8:111,275,973...111,355,491
Ensembl chr 8:111,276,354...111,355,092
G
Trib1
tribbles pseudokinase 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TRIB1 mRNA
CTD
PMID:36139627
NCBI chr 7:91,206,579...91,213,126
Ensembl chr 7:91,206,579...91,214,731
G
Trib2
tribbles pseudokinase 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TRIB2 mRNA
CTD
PMID:36139627
NCBI chr 6:38,545,971...38,570,349
Ensembl chr 6:38,545,975...38,569,370
G
Trim29
tripartite motif-containing 29
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TRIM29 mRNA
CTD
PMID:36139627
NCBI chr 8:43,682,221...43,706,992
Ensembl chr 8:43,682,221...43,706,992
G
Trim63
tripartite motif containing 63
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TRIM63 mRNA
CTD
PMID:36139627
NCBI chr 5:146,533,492...146,547,332
Ensembl chr 5:146,533,507...146,547,322
G
Trim9
tripartite motif-containing 9
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TRIM9 mRNA
CTD
PMID:36139627
NCBI chr 6:88,756,824...88,856,588
Ensembl chr 6:88,757,303...88,856,542
G
Trmt9b
tRNA methyltransferase 9B (putative)
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TRMT9B mRNA
CTD
PMID:36139627
NCBI chr16:55,740,551...55,792,198
Ensembl chr16:55,743,018...55,792,144
G
Trpv2
transient receptor potential cation channel, subfamily V, member 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TRPV2 mRNA
CTD
PMID:36139627
NCBI chr10:47,265,524...47,294,263
Ensembl chr10:47,272,931...47,294,260
G
Tsc22d3
TSC22 domain family, member 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TSC22D3 mRNA
CTD
PMID:36139627
NCBI chr X:104,217,898...104,277,886
Ensembl chr X:104,217,925...104,276,861
G
Tsnaxip1
translin-associated factor X interacting protein 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TSNAXIP1 mRNA
CTD
PMID:36139627
NCBI chr19:33,716,834...33,734,824
Ensembl chr19:33,716,785...33,734,824
G
Ttc39a
tetratricopeptide repeat domain 39A
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TTC39A mRNA
CTD
PMID:36139627
NCBI chr 5:124,165,102...124,204,740
Ensembl chr 5:124,151,760...124,204,973
G
Ttpa
alpha tocopherol transfer protein
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TTPA mRNA
CTD
PMID:36139627
NCBI chr 5:33,497,537...33,518,936
Ensembl chr 5:33,497,137...33,518,073
G
Tuba1a
tubulin, alpha 1A
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of TUBA1A mRNA
CTD
PMID:36139627
NCBI chr 7:130,113,214...130,116,880
Ensembl chr 7:130,081,032...130,196,186
G
Txk
TXK tyrosine kinase
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of TXK mRNA
CTD
PMID:36139627
NCBI chr14:35,463,369...35,519,448
Ensembl chr14:35,463,944...35,519,448
G
Uap1l1
UDP-N-acetylglucosamine pyrophosphorylase 1 like 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of UAP1L1 mRNA
CTD
PMID:36139627
NCBI chr 3:8,172,335...8,180,505
Ensembl chr 3:8,173,216...8,180,443
G
Uba7
ubiquitin-like modifier activating enzyme 7
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of UBA7 mRNA
CTD
PMID:36139627
NCBI chr 8:108,665,289...108,674,097
Ensembl chr 8:108,665,292...108,674,099
G
Ufsp1
UFM1-specific peptidase 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of UFSP1 mRNA
CTD
PMID:36139627
NCBI chr12:19,406,133...19,407,147
Ensembl chr12:19,406,142...19,407,195
G
Uhrf2
ubiquitin like with PHD and ring finger domains 2
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of UHRF2 mRNA
CTD
PMID:36139627
NCBI chr 1:227,814,639...227,877,907
Ensembl chr 1:227,814,963...227,877,904
G
Upk1a
uroplakin 1A
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of UPK1A mRNA
CTD
PMID:36139627
NCBI chr 1:85,859,672...85,870,147
Ensembl chr 1:85,859,671...85,870,354
G
Upk3b
uroplakin 3B
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of UPK3B mRNA
CTD
PMID:36139627
NCBI chr12:20,630,231...20,637,634
Ensembl chr12:20,631,525...20,637,724
G
Ush1g
USH1 protein network component sans
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of USH1G mRNA
CTD
PMID:36139627
NCBI chr10:100,559,721...100,563,590
Ensembl chr10:100,557,629...100,563,590
G
Vdr
vitamin D receptor
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of VDR mRNA
CTD
PMID:36139627
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Veph1
ventricular zone expressed PH domain-containing 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of VEPH1 mRNA
CTD
PMID:36139627
NCBI chr 2:150,291,379...150,537,491
Ensembl chr 2:150,296,573...150,537,266
G
Vgf
VGF nerve growth factor inducible
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of VGF mRNA
CTD
PMID:36139627
NCBI chr12:19,637,313...19,645,123
Ensembl chr12:19,637,320...19,640,341
G
Vtn
vitronectin
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of VTN mRNA
CTD
PMID:36139627
NCBI chr10:63,394,732...63,397,812
Ensembl chr10:63,394,719...63,397,810
G
Wasf3
WASP family member 3
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of WASF3 mRNA
CTD
PMID:36139627
NCBI chr12:8,563,805...8,660,799
Ensembl chr12:8,562,062...8,660,751
G
Wnt10b
Wnt family member 10B
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of WNT10B mRNA
CTD
PMID:36139627
NCBI chr 7:129,922,088...129,927,892
Ensembl chr 7:129,922,088...129,927,892
G
Wnt11
Wnt family member 11
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of WNT11 mRNA
CTD
PMID:36139627
NCBI chr 1:153,134,503...153,154,294
Ensembl chr 1:153,138,197...153,154,294
G
Wnt2b
Wnt family member 2B
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of WNT2B mRNA
CTD
PMID:36139627
NCBI chr 2:192,454,226...192,468,599
Ensembl chr 2:192,453,824...192,470,308
G
Wnt4
Wnt family member 4
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of WNT4 mRNA
CTD
PMID:36139627
NCBI chr 5:149,513,573...149,535,415
Ensembl chr 5:149,514,018...149,532,859
G
Wnt7b
Wnt family member 7B
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of WNT7B mRNA
CTD
PMID:36139627
NCBI chr 7:116,634,817...116,679,459
Ensembl chr 7:116,634,814...116,679,581
G
Wnt8b
Wnt family member 8B
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of WNT8B mRNA
CTD
PMID:36139627
NCBI chr 1:243,354,145...243,376,000
Ensembl chr 1:243,354,086...243,374,286
G
Xaf1
XIAP associated factor 1
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of XAF1 mRNA
CTD
PMID:36139627
NCBI chr10:56,917,378...56,929,791
Ensembl chr10:56,917,121...56,929,770
G
Zc3h6
zinc finger CCCH type containing 6
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ZC3H6 mRNA
CTD
PMID:36139627
NCBI chr 3:116,203,466...116,254,186
Ensembl chr 3:116,204,197...116,253,282
G
Zfp608
zinc finger protein 608
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of ZNF608 mRNA
CTD
PMID:36139627
NCBI chr18:48,304,873...48,412,846
Ensembl chr18:48,304,880...48,410,465
G
Zwint
ZW10 interacting kinetochore protein
multiple interactions
ISO
[sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of ZWINT mRNA
CTD
PMID:36139627
NCBI chr20:15,938,157...15,953,997
Ensembl chr20:15,938,157...15,953,957
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all